<!DOCTYPE html> <html lang="en" dir="ltr" prefix="og: https://ogp.me/ns#"> <head> <meta charset="utf-8" /><script type="text/javascript">(window.NREUM||(NREUM={})).loader_config={licenseKey:"761e715901",applicationID:"35893545"};window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var i=n[t]={exports:{}};e[t][0].call(i.exports,function(n){var i=e[t][1][n];return r(i||n)},i,i.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var i=0;i<t.length;i++)r(t[i]);return r}({1:[function(e,n,t){function r(){}function i(e,n,t){return function(){return o(e,[u.now()].concat(f(arguments)),n?null:this,t),n?void 0:this}}var o=e("handle"),a=e(4),f=e(5),c=e("ee").get("tracer"),u=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",d=l+"ixn-";a(p,function(e,n){s[n]=i(l+n,!0,"api")}),s.addPageAction=i(l+"addPageAction",!0),s.setCurrentRouteName=i(l+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,i="function"==typeof n;return o(d+"tracer",[u.now(),e,t],r),function(){if(c.emit((i?"":"no-")+"fn-start",[u.now(),r,i],t),i)try{return n.apply(this,arguments)}catch(e){throw c.emit("fn-err",[arguments,this,e],t),e}finally{c.emit("fn-end",[u.now()],t)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=i(d+n)}),newrelic.noticeError=function(e,n){"string"==typeof e&&(e=new Error(e)),o("err",[e,u.now(),!1,n])}},{}],2:[function(e,n,t){function r(e,n){var t=e.getEntries();t.forEach(function(e){"first-paint"===e.name?c("timing",["fp",Math.floor(e.startTime)]):"first-contentful-paint"===e.name&&c("timing",["fcp",Math.floor(e.startTime)])})}function i(e,n){var t=e.getEntries();t.length>0&&c("lcp",[t[t.length-1]])}function o(e){if(e instanceof s&&!l){var n,t=Math.round(e.timeStamp);n=t>1e12?Date.now()-t:u.now()-t,l=!0,c("timing",["fi",t,{type:e.type,fid:n}])}}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var a,f,c=e("handle"),u=e("loader"),s=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){a=new PerformanceObserver(r),f=new PerformanceObserver(i);try{a.observe({entryTypes:["paint"]}),f.observe({entryTypes:["largest-contentful-paint"]})}catch(p){}}if("addEventListener"in document){var l=!1,d=["click","keydown","mousedown","pointerdown","touchstart"];d.forEach(function(e){document.addEventListener(e,o,!1)})}}},{}],3:[function(e,n,t){function r(e,n){if(!i)return!1;if(e!==i)return!1;if(!n)return!0;if(!o)return!1;for(var t=o.split("."),r=n.split("."),a=0;a<r.length;a++)if(r[a]!==t[a])return!1;return!0}var i=null,o=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var f=navigator.userAgent,c=f.match(a);c&&f.indexOf("Chrome")===-1&&f.indexOf("Chromium")===-1&&(i="Safari",o=c[1])}n.exports={agent:i,version:o,match:r}},{}],4:[function(e,n,t){function r(e,n){var t=[],r="",o=0;for(r in e)i.call(e,r)&&(t[o]=n(r,e[r]),o+=1);return t}var i=Object.prototype.hasOwnProperty;n.exports=r},{}],5:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,i=t-n||0,o=Array(i<0?0:i);++r<i;)o[r]=e[n+r];return o}n.exports=r},{}],6:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function i(e){function n(e){return e&&e instanceof r?e:e?c(e,f,o):o()}function t(t,r,i,o){if(!l.aborted||o){e&&e(t,r,i);for(var a=n(i),f=v(t),c=f.length,u=0;u<c;u++)f[u].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function d(e,n){h[e]=v(e).concat(n)}function m(e,n){var t=h[e];if(t)for(var r=0;r<t.length;r++)t[r]===n&&t.splice(r,1)}function v(e){return h[e]||[]}function g(e){return p[e]=p[e]||i(t)}function w(e,n){u(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var h={},y={},b={on:d,addEventListener:d,removeEventListener:m,emit:t,get:g,listeners:v,context:n,buffer:w,abort:a,aborted:!1};return b}function o(){return new r}function a(){(s.api||s.feature)&&(l.aborted=!0,s=l.backlog={})}var f="nr@context",c=e("gos"),u=e(4),s={},p={},l=n.exports=i();l.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(i.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(o){}return e[n]=r,r}var i=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){i.buffer([e],r),i.emit(e,n,t)}var i=e("ee").get("handle");n.exports=r,r.ee=i},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,o,function(){return i++})}var i=1,o="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=E.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();u(y,function(n,t){e[n]||(e[n]=t)}),c("mark",["onload",a()+E.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function i(){"complete"===d.readyState&&o()}function o(){c("mark",["domContent",a()+E.offset],null,"api")}function a(){return O.exists&&performance.now?Math.round(performance.now()):(f=Math.max((new Date).getTime(),f))-E.offset}var f=(new Date).getTime(),c=e("handle"),u=e(4),s=e("ee"),p=e(3),l=window,d=l.document,m="addEventListener",v="attachEvent",g=l.XMLHttpRequest,w=g&&g.prototype;NREUM.o={ST:setTimeout,SI:l.setImmediate,CT:clearTimeout,XHR:g,REQ:l.Request,EV:l.Event,PR:l.Promise,MO:l.MutationObserver};var h=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1169.min.js"},b=g&&w&&w[m]&&!/CriOS/.test(navigator.userAgent),E=n.exports={offset:f,now:a,origin:h,features:{},xhrWrappable:b,userAgent:p};e(1),e(2),d[m]?(d[m]("DOMContentLoaded",o,!1),l[m]("load",r,!1)):(d[v]("onreadystatechange",i),l[v]("onload",r)),c("mark",["firstbyte",f],null,"api");var x=0,O=e(6)},{}],"wrap-function":[function(e,n,t){function r(e){return!(e&&e instanceof Function&&e.apply&&!e[a])}var i=e("ee"),o=e(5),a="nr@original",f=Object.prototype.hasOwnProperty,c=!1;n.exports=function(e,n){function t(e,n,t,i){function nrWrapper(){var r,a,f,c;try{a=this,r=o(arguments),f="function"==typeof t?t(r,a):t||{}}catch(u){l([u,"",[r,a,i],f])}s(n+"start",[r,a,i],f);try{return c=e.apply(a,r)}catch(p){throw s(n+"err",[r,a,p],f),p}finally{s(n+"end",[r,a,c],f)}}return r(e)?e:(n||(n=""),nrWrapper[a]=e,p(e,nrWrapper),nrWrapper)}function u(e,n,i,o){i||(i="");var a,f,c,u="-"===i.charAt(0);for(c=0;c<n.length;c++)f=n[c],a=e[f],r(a)||(e[f]=t(a,u?f+i:i,o,f))}function s(t,r,i){if(!c||n){var o=c;c=!0;try{e.emit(t,r,i,n)}catch(a){l([a,t,r,i])}c=o}}function p(e,n){if(Object.defineProperty&&Object.keys)try{var t=Object.keys(e);return t.forEach(function(t){Object.defineProperty(n,t,{get:function(){return e[t]},set:function(n){return e[t]=n,n}})}),n}catch(r){l([r])}for(var i in e)f.call(e,i)&&(n[i]=e[i]);return n}function l(n){try{e.emit("internal-error",n)}catch(t){}}return e||(e=i),t.inPlace=u,t.flag=a,t}},{}]},{},["loader"]);</script> <meta property="og:site_name" content="Novavax Inc. - IR Site" /> <meta property="og:type" content="website" /> <meta property="og:title" content="PRESS RELEASES | Novavax Inc. - IR Site" /> <meta name="referrer" content="no-referrer" /> <meta name="Generator" content="Drupal 8 (https://www.drupal.org)" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <link rel="shortcut icon" href="/sites/g/files/knoqqb54086/files/favicon.ico" type="image/vnd.microsoft.icon" /> <link rel="alternate" hreflang="en" href="https://ir.novavax.com/press-releases" /> <link rel="canonical" href="https://ir.novavax.com/press-releases" /> <link rel="shortlink" href="https://ir.novavax.com/node/5816" /> <link rel="revision" href="https://ir.novavax.com/press-releases" /> <title>PRESS RELEASES | Investor Relations | Novavax Inc. - IR Site</title> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb54086/files/css/css__VlyXXGoApi-8_z_B0iVdTEfUHuUF_Wp8qcENSFXC9Y.css" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb54086/files/css/css_94_w55St1hj-ry6pldVvE_BVtmSypLAl1P_6swdGHBQ.css" /> <link rel="stylesheet" media="all" href="//fonts.googleapis.com/css2?family=IBM+Plex+Sans:ital,wght@0,400;0,500;0,700;1,400&amp;display=swap" /> <link rel="stylesheet" media="all" href="//fonts.googleapis.com/css2?family=Montserrat:wght@400;600;800&amp;display=swap" /> <link rel="stylesheet" media="all" href="/sites/g/files/knoqqb54086/files/css/css_gCOfWGbhM04lOyvo3BY5PaJNqwji-arfbJ4-YKR9vWI.css" /> <link rel="stylesheet" media="print" href="/sites/g/files/knoqqb54086/files/css/css_uR7CBnjEs5VZNOTbN5egaIVEsuJ_uLDLaCxQpDsgq_0.css" /> <!--[if lte IE 8]> <script src="/sites/g/files/knoqqb54086/files/js/js_VtafjXmRvoUgAzqzYTA3Wrjkx9wcWhjP0G4ZnnqRamA.js"></script> <![endif]--> <script src="/core/assets/vendor/modernizr/modernizr.min.js?v=3.3.1"></script> </head> <body class="body-sidebars-none nir-node nir-node--type-nir-landing-page nir-node--5816 page-node-5816 path-node page-node-type-nir-landing-page"> <div id="skip"> <a class="visually-hidden focusable skip-link" href="#main-menu"> Skip to main navigation </a> </div> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <header id="page-header"> <div class="on-hover-bg"> <div class="container"> <div class="header-logo"> <a href="https://novavax.com"> <img src="/sites/g/files/knoqqb54086/themes/site/nir_pid165/client/new-images/novavax-logo.png" alt=""> </a> </div> <div class="header-navigation header-navigation--desktop"> <nav id="utility-nav" role="navigation" aria-label="utility"> <ul class="nav-items"> <li class="nav-item menu-item--expanded"> <a href="/" target="" rel="" data-drupal-link-system-path="&lt;front&gt;">For Investors</a> <ul class="sub-nav-item-sections sub-nav-items"> <li class="nav-item"> <a href="https://novavax.com/about-us#corporate-governance" target="" rel="">Corporate Governance</a> </li> <li class="nav-item"> <a href="/stock-information/stock-quote-chart" target="" rel="" data-drupal-link-system-path="node/5911">Stock Information</a> </li> <li class="nav-item"> <a href="/events" target="" rel="" data-drupal-link-system-path="node/5826">Events</a> </li> <li class="nav-item"> <a href="/sec-filings" target="" rel="" data-drupal-link-system-path="node/13076">SEC Filings</a> </li> <li class="nav-item"> <a href="https://novavax.com/analyst-coverage" target="" rel="">Analyst Coverage</a> </li> <li class="nav-item"> <a href="https://novavax.com/investor-relations-contact" target="" rel="">Investor Relations Contact</a> </li> <li class="nav-item"> <a href="https://novavax.com/download/files/ar/NVAX_2019_Annual_Report_FINAL.pdf" target="_blank" rel="">Annual Report</a> </li> <li class="nav-item"> <a href="https://novavax.com/20200116-JPM-Presentation.pdf" target="_blank" rel="">Investor Presentation</a> </li> </ul> </li> <li class="nav-item menu-item--expanded menu-item--active-trail"> <a href="https://novavax.com/novavax-in-the-news" target="" rel="">News</a> <ul class="sub-nav-item-sections sub-nav-items"> <li class="nav-item menu-item--active-trail"> <a href="/press-releases" target="" rel="" data-drupal-link-system-path="node/5816" class="is-active">Press Releases</a> </li> <li class="nav-item"> <a href="https://novavax.com/novavax-in-the-news" target="" rel="">Novavax in the News</a> </li> <li class="nav-item"> <a href="/join-press-release-list" target="" rel="" data-drupal-link-system-path="node/13161">Join the Press Release List</a> </li> </ul> </li> <li class="nav-item"> <a href="https://novavax.com/careers" target="" rel="">Careers</a> </li> <li class="nav-item"> <a href="https://novavax.com/contact-us" target="" rel="">Contact Us</a> </li> </ul> </nav> <nav id="primary-nav" role="navigation" aria-label="main" class=""> <ul class="nav-items"> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="https://novavax.com/about-us" target="" rel="">About Us</a> </li> <li class="nav-item nav-item--primary" id="nav-item-pipeline"> <a href="https://novavax.com/our-pipeline" target="" rel="">Our Pipeline</a> </li> <li class="nav-item nav-item--primary" id="nav-item-science"> <a href="https://novavax.com/science-and-technology-overview" target="" rel="">Science and Technology</a> </li> <li class="nav-item nav-item--primary" id="nav-item-resources"> <a href="https://novavax.com/resources" target="" rel="">Resources</a> </li> </ul> <div class="nav-trigger"></div> </nav> </div> <div class="header-navigation header-navigation--mobile"> <nav id="mobile-nav" role="navigation" aria-label="mobile"> <ul class="nav-items"> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="https://novavax.com/about-us" target="" rel="">About Us</a> </li> <li class="nav-item nav-item--primary" id="nav-item-pipeline"> <a href="https://novavax.com/our-pipeline" target="" rel="">Our Pipeline</a> </li> <li class="nav-item nav-item--primary" id="nav-item-science"> <a href="https://novavax.com/science-and-technology-overview" target="" rel="">Science and Technology</a> </li> <li class="nav-item nav-item--primary" id="nav-item-resources"> <a href="https://novavax.com/resources" target="" rel="">Resources</a> </li> <hr/> <li class="nav-item nav-item--primary menu-item--expanded" id="nav-item-about-us"> <a href="/" target="" rel="" data-drupal-link-system-path="&lt;front&gt;">For Investors</a> <ul class="sub-nav-item-sections"> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="https://novavax.com/about-us#corporate-governance" target="" rel="">Corporate Governance</a> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="/stock-information/stock-quote-chart" target="" rel="" data-drupal-link-system-path="node/5911">Stock Information</a> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="/events" target="" rel="" data-drupal-link-system-path="node/5826">Events</a> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="/sec-filings" target="" rel="" data-drupal-link-system-path="node/13076">SEC Filings</a> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="https://novavax.com/analyst-coverage" target="" rel="">Analyst Coverage</a> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="https://novavax.com/investor-relations-contact" target="" rel="">Investor Relations Contact</a> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="https://novavax.com/download/files/ar/NVAX_2019_Annual_Report_FINAL.pdf" target="_blank" rel="">Annual Report</a> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="https://novavax.com/20200116-JPM-Presentation.pdf" target="_blank" rel="">Investor Presentation</a> </li> </ul> <img class="mobile-item-toggle" src="/sites/g/files/knoqqb54086/themes/site/nir_pid165/client/new-images/expand-white.png"> </li> <li class="nav-item nav-item--primary menu-item--expanded menu-item--active-trail" id="nav-item-about-us"> <a href="https://novavax.com/novavax-in-the-news" target="" rel="">News</a> <ul class="sub-nav-item-sections"> <li class="nav-item nav-item--primary menu-item--active-trail" id="nav-item-about-us"> <a href="/press-releases" target="" rel="" data-drupal-link-system-path="node/5816" class="is-active">Press Releases</a> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="https://novavax.com/novavax-in-the-news" target="" rel="">Novavax in the News</a> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="/join-press-release-list" target="" rel="" data-drupal-link-system-path="node/13161">Join the Press Release List</a> </li> </ul> <img class="mobile-item-toggle" src="/sites/g/files/knoqqb54086/themes/site/nir_pid165/client/new-images/expand-white.png"> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="http://novavax.com/careers" target="" rel="">Careers</a> </li> <li class="nav-item nav-item--primary" id="nav-item-about-us"> <a href="http://novavax.com/contact-us" target="" rel="">Contact Us</a> </li> </ul> <div class="nav-trigger"></div> </nav> <div class="header-mobile-toggle"> <div class="header-mobile-toggle-inner"> </div> </div> </div> </div> </div> </header> <div id="page-wrapper" class="news-tpl"> <div class="popup"> <div class="back-layer"></div> <div class="content-wrap"></div> </div> <input type="hidden" id="image_path" name="image_path" value="/sites/g/files/knoqqb54086/themes/site/nir_pid165"> <section class="pixbar" id="press-banner" style="background-image: url(/sites/g/files/knoqqb54086/themes/site/nir_pid165/client/images/press-release.jpg);"></section> <div class="page-title"> <div class="container"> <h1 class="desktop-title" id="desktop-title"></h1> <h1 class="mobile-title" id="mobile-title"></h1> </div> </div> <div id="nir-header"> <div class="container"> </div> </div> <div class="clearfix" id="main"> <div class="container"> <section id="content"> <div id="content-header"> </div> <div id="content-area"> <div class="region region-content"> <div id="block-nir-pid165-websitenoticeblock" class="block--website-notice-block block--website-notice-block--5816 block--content--website-notice-block block--content--website-notice-block--5816 block--1e4bdc27-1966-4c8e-8795-797415faf6c4 block--1e4bdc27-1966-4c8e-8795-797415faf6c4--5816 block block-nir-website-notices block-website-notice-block"> </div> <div data-drupal-messages-fallback class="hidden"></div> <div id="block-nir-pid165-content" class="block--system-main-block block--system-main-block--5816 block--content--system-main-block block--content--system-main-block--5816 block--56f707b1-05c7-4b95-b5b4-26110946da21 block--56f707b1-05c7-4b95-b5b4-26110946da21--5816 block block-system block-system-main-block"> <article class="node node--type-nir_landing_page node--view-mode-full clearfix"> <h1> PRESS RELEASES </h1> <div> <div class="panel-display boxton clearfix " > <div class="container-fluid"> <div class="row"> <div class="col-md-12 radix-layouts-content panel-panel"> <div class="panel-panel-inner"> <div class="block-region-contentmain"> <nav role="navigation" aria-labelledby="-menu" class="block--system-menu-blockpress-releases-years block--system-menu-blockpress-releases-years--5816 block--contentmain--system-menu-block--press-releases-years block--contentmain--system-menu-block--press-releases-years--5816 block--15728b34-e37e-4b42-a8a7-056a02bb4574 block--15728b34-e37e-4b42-a8a7-056a02bb4574--5816 block block-menu navigation block-system-menublock menu--press-releases-years"> <h2 class="visually-hidden" id="-menu">Press Releases Years</h2> <ul data-block-uuid="15728b34-e37e-4b42-a8a7-056a02bb4574" class="menu side-menu"> <li class="side-menu__item"> <a href="/press-releases?field_nir_news_date_value%5Bmin%5D=2020" target="" rel="" data-drupal-link-query="{&quot;field_nir_news_date_value&quot;:{&quot;min&quot;:&quot;2020&quot;}}" data-drupal-link-system-path="node/5816">2020</a> </li> <li class="side-menu__item"> <a href="/press-releases?field_nir_news_date_value%5Bmin%5D=2019" target="" rel="" data-drupal-link-query="{&quot;field_nir_news_date_value&quot;:{&quot;min&quot;:&quot;2019&quot;}}" data-drupal-link-system-path="node/5816">2019</a> </li> <li class="side-menu__item"> <a href="/press-releases?field_nir_news_date_value%5Bmin%5D=2018" target="" rel="" data-drupal-link-query="{&quot;field_nir_news_date_value&quot;:{&quot;min&quot;:&quot;2018&quot;}}" data-drupal-link-system-path="node/5816">2018</a> </li> <li class="side-menu__item"> <a href="/press-releases?field_nir_news_date_value%5Bmin%5D=2017" data-drupal-link-query="{&quot;field_nir_news_date_value&quot;:{&quot;min&quot;:&quot;2017&quot;}}" data-drupal-link-system-path="node/5816">2017</a> </li> <li class="side-menu__item"> <a href="/press-releases?field_nir_news_date_value%5Bmin%5D=2016" data-drupal-link-query="{&quot;field_nir_news_date_value&quot;:{&quot;min&quot;:&quot;2016&quot;}}" data-drupal-link-system-path="node/5816">2016</a> </li> <li class="side-menu__item"> <a href="/press-releases?field_nir_news_date_value%5Bmin%5D=2015" data-drupal-link-query="{&quot;field_nir_news_date_value&quot;:{&quot;min&quot;:&quot;2015&quot;}}" data-drupal-link-system-path="node/5816">2015</a> </li> </ul> </nav> <div class="views-element-container block--views-blockwidget-news-widget-news-ul block--views-blockwidget-news-widget-news-ul--5816 block--contentmain--views-block--widget-news-widget-news-ul block--contentmain--views-block--widget-news-widget-news-ul--5816 block--50c31fb3-aff1-4025-a7e8-2fc746cc71b9 block--50c31fb3-aff1-4025-a7e8-2fc746cc71b9--5816 block block-views block-views-blockwidget-news-widget-news-ul"> <div data-block-uuid="50c31fb3-aff1-4025-a7e8-2fc746cc71b9"><div class="view view-widget-news view-id-widget_news view-display-id-widget_news_ul js-view-dom-id-3cc4a118af6e1fc4356cbebff6bc9c24c83dfbf6316013eb9179404512708ec4"> <div class="view-filters"> <form class="views-exposed-form" data-drupal-selector="views-exposed-form-widget-news-widget-news-ul" action="/press-releases" method="get" id="views-exposed-form-widget-news-widget-news-ul" accept-charset="UTF-8"> <div class="form--inline clearfix"> <div class="js-form-item form-item js-form-type-select form-item-field-nir-news-date-value-min js-form-item-field-nir-news-date-value-min"> <label for="edit-field-nir-news-date-value-min">Year:</label> <select data-drupal-selector="edit-field-nir-news-date-value-min" id="edit-field-nir-news-date-value-min" name="field_nir_news_date_value[min]" size="1" class="form-select"><option value="" selected="selected">- Any -</option><option value="2020">2020</option><option value="2019">2019</option><option value="2018">2018</option><option value="2017">2017</option><option value="2016">2016</option><option value="2015">2015</option><option value="2014">2014</option><option value="2013">2013</option><option value="2012">2012</option><option value="2011">2011</option><option value="2010">2010</option><option value="2009">2009</option><option value="2008">2008</option><option value="2007">2007</option><option value="2006">2006</option><option value="2005">2005</option><option value="2004">2004</option><option value="2003">2003</option><option value="2002">2002</option></select> </div> <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"><input data-drupal-selector="edit-submit-widget-news" type="submit" id="edit-submit-widget-news" value="Filter" class="button js-form-submit form-submit" /> <input data-drupal-selector="edit-reset" type="submit" id="edit-reset" name="op" value="Reset" class="button js-form-submit form-submit" /> </div> </div> </form> </div> <div class="view-content"> <div class="item-list"> <span class="ccbnLnk moreLink"><a href="/press-releases">More</a>>></span> <ul> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 02, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-updates-leadership-team" hreflang="en">Novavax Announces Updates to Leadership Team</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Frank Czworka appointed SVP, Global Sales Brian Webb promoted to SVP, Manufacturing GAITHERSBURG, Md. , July 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 29, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-expands-executive-leadership-and-announces-key" hreflang="en">Novavax Expands Executive Leadership and Announces Key Promotions</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 29, 2020 (GLOBE NEWSWIRE) -- Novavax , Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Ben Machielse as Executive Vice President, CMC, with responsibility for...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 24, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-participate-hc-wainwright-fireside-chat-series" hreflang="en">Novavax to Participate in H.C. Wainwright Fireside Chat Series</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 24, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that John J. Trizzino , Senior Vice President, Chief Business Officer and Chief Financial...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 17, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-additions-executive-leadership" hreflang="en">Novavax Announces Additions to Executive Leadership</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Dr. Filip Dubovsky appointed SVP, Chief Medical Officer Silvia Taylor appointed SVP, Investor Relations and Corporate Affairs GAITHERSBURG, Md. , June 17, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 16, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-biotechnology-veteran-david-mott-board" hreflang="en">Novavax Appoints Biotechnology Veteran David Mott to Board of Directors</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 16, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has appointed David Mott as an independent director to its Board of Directors. Mr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 15, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-raise-200-million-private-placement-ra-capital" hreflang="en">Novavax to Raise $200 Million from Private Placement with RA Capital</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 15, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has entered into an agreement to sell Series A Convertible preferred stock, convertible...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 08, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-president-rd-dr-gregory-glenn-discuss-development-covid" hreflang="en">Novavax President of R&amp;D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 08, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory M. Glenn , M.D., President of Research and Development, will join other vaccine...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 04, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-awarded-department-defense-contract-covid-19-vaccine" hreflang="en">Novavax Awarded Department of Defense Contract for COVID-19 Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>$60 million funding for manufacturing of NVX-CoV2373 10 million doses to be delivered to DoD in 2020 GAITHERSBURG, Md. , June 04, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 27, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-expands-large-scale-global-manufacturing-capacity" hreflang="en">Novavax Expands Large-Scale Global Manufacturing Capacity</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Novavax acquires Praha Vaccines in Czech Republic Annual operating capacity of over 1 billion doses of COVID-19 vaccine antigen GAITHERSBURG, Md. , May 27, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 25, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-12-clinical-trial-covid-19-vaccine" hreflang="en">Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>First participants enrolled in Phase 1 portion of clinical trial of NVX‑CoV2373 Preliminary immunogenicity and safety results expected in July 2020 Phase 2 portion to begin promptly following successful Phase 1 results GAITHERSBURG, Md. , May 25, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 11, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2020-financial-results" hreflang="en">Novavax Reports First Quarter 2020 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>CEPI increases investment up to $388 million for NVX‑CoV2373 vaccine development &amp;amp; manufacturing NVX ‑ CoV2373 Phase I trial initiating in May with preliminary results in July NanoFlu recently achieved all primary endpoints in pivotal Phase 3 clinical trial Company to host conference call today at...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 11, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-receive-388-million-funding-cepi-covid-19-vaccine" hreflang="en">Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Funds clinical development of NVX-CoV2373 through Phase 2 Supports rapid scale-up of vaccine manufacturing Allows for increased production of Matrix-M adjuvant Reserves global large-scale manufacturing capacity GAITHERSBURG, Md. , May 11, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 11, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-covid-19-vaccine-candidate-progress-world" hreflang="en">Novavax to Present COVID-19 Vaccine Candidate Progress in World Vaccine Congress Webinar Series</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 11, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Gregory Glenn , M.D., President of Research and Development, will present progress of...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 06, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-first-quarter-financial-3" hreflang="en">Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 11, 2020</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 06, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report its first quarter 2020 financial and operating results following the close of...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 08, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-identifies-coronavirus-vaccine-candidate-accelerates" hreflang="en">Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NVX-CoV2373 identified as SARS-CoV-2 candidate for Phase 1 clinical trial In preclinical studies, NVX-CoV2373 demonstrated high immunogenicity and stimulated high levels of neutralizing antibodies First-in-human Phase 1 clinical trial accelerated to mid-May with preliminary results in July GMP...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 24, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-nanoflu-achieves-all-primary-endpoints-phase-3-clinical" hreflang="en">Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Trial also achieves statistical significance in key secondary endpoints Novavax to submit a U.S. BLA under FDA’s accelerated approval pathway Company to host investor conference call today at 8:30 a.m. EDT GAITHERSBURG, Md. , March 24, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 11, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-full-year-2019-financial" hreflang="en">Novavax Reports Fourth Quarter and Full Year 2019 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NanoFlu top-line data from Phase 3 clinical trial expected by the end of this month Novavax awarded CEPI funding to support COVID-19 vaccine program COVID-19 Phase 1 clinical trial expected to initiate in late spring of 2020 Company to host conference call today at 4:30 p.m. ET GAITHERSBURG, Md....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 11, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-serum-institute-india-develop-and-commercialize" hreflang="en">Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Novavax’ proprietary Matrix-M vaccine adjuvant enhances immune response of malaria antigen developed at Jenner Institute at Oxford University Phase 2b clinical efficacy study of experimental malaria vaccine with Matrix‑M nearing completion in Burkina Faso GAITHERSBURG, Md....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 10, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-awarded-funding-cepi-covid-19-vaccine-development" hreflang="en">Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>CEPI to provide an initial $4 million to accelerate vaccine development to prepare for Phase 1 Multiple vaccine candidates being tested in preclinical studies prior to advancing to human trials Phase 1 clinical trial expected to initiate in late spring of 2020 GAITHERSBURG, Md....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 05, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-fourth-quarter-financial" hreflang="en">Novavax to Host Conference Call to Discuss Fourth Quarter Financial Results on March 11, 2020</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , March 05, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report its fourth quarter 2019 financial and operating results following the close of...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 26, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-advances-development-novel-covid-19-vaccine" hreflang="en">Novavax Advances Development of Novel COVID-19 Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Vaccine candidate derived from coronavirus spike (S) protein Matrix-M™ adjuvant expected to boost immune responses Phase 1 clinical trial planned for late spring GAITHERSBURG, Md. , Feb. 26, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 25, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-preclinical-nanoflu-data-published-vaccines-details" hreflang="en">Novavax’ Preclinical NanoFlu Data Published in Vaccines; Details Structural Basis for Broadly Neutralizing Immunity</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Feb. 25, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced a publication in Vaccines describing the immunogenic potential of NanoFlu™, Novavax’...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 15, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-granted-fast-track-designation-nanoflu-older-adults" hreflang="en">Novavax Granted Fast Track Designation for NanoFlu in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 15, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. Food and Drug Administration ( FDA ) has granted Fast Track Designation for...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 09, 2020 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-38th-annual-jp-morgan-healthcare-conference" hreflang="en">Novavax to Present at the 38th Annual J.P. Morgan Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 07, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2019-financial-results" hreflang="en">Novavax Reports Third Quarter 2019 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NanoFlu pivotal Phase 3 clinical trial initiated October 2019 with top-line data expected in the first quarter of 2020 Company to host conference call today at 4:30 p.m. ET GAITHERSBURG, Md. , Nov. 07, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 31, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-third-quarter-financial-2" hreflang="en">Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2019</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 31, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report its third quarter 2019 financial and operating results following the close of...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 15, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-pivotal-phase-3-clinical-trial-nanoflu" hreflang="en">Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>First participants enrolled in pivotal Phase 3 clinical trial of NanoFlu Top-line clinical data expected in the first quarter of 2020 Phase 3 results expected to support a future BLA and licensure of NanoFlu using the FDA’s accelerated approval pathway GAITHERSBURG, Md. , Oct....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 19, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-ladenburg-thalmann-2019-healthcare-conference" hreflang="en">Novavax to Present at the Ladenburg Thalmann 2019 Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 19, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Stanley C. Erck , President and Chief Executive Officer, will present at the Ladenburg...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 06, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-hc-wainwright-21st-annual-global-investment" hreflang="en">Novavax to Present at the H.C. Wainwright 21st Annual Global Investment Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 06, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Stanley C. Erck , President and Chief Executive Officer, will present at the H. C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 12, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/new-data-novavax-phase-3-preparetm-trial-resvaxtm-presented-0" hreflang="en">New Data from Novavax Phase 3 Prepare™ Trial of ResVax™ Presented at 2019 IDSOG Annual Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Data demonstrate significant vaccine efficacy against infant pneumonia through the first year of life GAITHERSBURG, Md., August 12, 2019 – Novavax, Inc. (NASDAQ: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 08, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-scientific-leadership-present-new-rsv-maternal" hreflang="en">Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 08, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that Louis F. Fries III , M.D., Senior Vice President, Chief Medical Officer, will participate...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 07, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-second-quarter-2019-financial-results" hreflang="en">Novavax Reports Second Quarter 2019 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Agreement with the FDA on Phase 3 non-inferiority immunogenicity study design for NanoFlu™ NanoFlu pivotal Phase 3 clinical trial expected to initiate in the third quarter of 2019 with top-line data in the first quarter of 2020 Strategic partnership completed with Catalent ; raised $18 million...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 05, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reaches-agreement-fda-pivotal-phase-3-trial-design" hreflang="en">Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Clinical trial expected to initiate in the fall of 2019 GAITHERSBURG, Md. , Aug. 05, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it received input from the U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 01, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-second-quarter-financial-2" hreflang="en">Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Gaithersburg, Md. , Aug. 01, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report its second quarter 2019 financial and operating results following the close of...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 31, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-catalent-announce-closing-strategic-partnership" hreflang="en">Novavax and Catalent Announce Closing of Strategic Partnership</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md., July 31, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Catalent Biologics’ Paragon Gene Therapy unit, the leading viral vector development and manufacturing...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 27, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-confirms-accelerated-approval-pathway-available" hreflang="en">Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Pivotal Phase 3 clinical trial expected to initiate in the fall of 2019 Top-line clinical data expected in the first quarter of 2020 GAITHERSBURG, Md. , June 27, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 27, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-catalent-biologics-enter-strategic-partnership" hreflang="en">Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Manufacturing equipment and related assets to be sold to Catalent’s Paragon Gene Therapy for $18 million in cash Over 100 manufacturing and quality employees to join Catalent Paragon Gene Therapy to take over two clinical development and manufacturing sites in Gaithersburg, MD Long-term agreement...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 10, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-provides-updates-global-pathways-licensure-resvaxtm" hreflang="en">Novavax Provides Updates on the Global Pathways to Licensure for ResVax™</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 10, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced updates on the pursuit of global licensure for ResVax™ following the Prepare™ Phase 3 clinical...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 04, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-cfo-john-trizzino-discuss-future-influenza-vaccines" hreflang="en">Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 04, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced that John J. Trizzino , Senior Vice President, Chief Business Officer and Chief Financial Officer, will join other vaccine industry leaders for a panel discussion at the 2019 BIO International...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 10, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-adjustment-conversion-rate-its-375-convertible" hreflang="en">Novavax Announces Adjustment of Conversion Rate for its 3.75% Convertible Senior Notes due 2023</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 10, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced an adjustment to the conversion rate applicable to its existing 3.75% Convertible Senior Notes due 2023 (Notes), pursuant to that certain Indenture between Novavax and The Bank of New York Mellon Trust...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 08, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-reverse-stock-split-common-stock" hreflang="en">Novavax Announces Reverse Stock Split of Common Stock</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 08, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will effect a one-for-twenty reverse stock split of its issued and outstanding common stock. Stockholders of Novavax approved an amendment to Novavax’ Second Amended and Restated Certificate of...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 02, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2019-financial-results" hreflang="en">Novavax Reports First Quarter 2019 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p> Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md. , May 02, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq: NVAX) today announced its financial results and operational highlights for the first quarter ended March 31, 2019 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 01, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-presentation-phase-3-data-rsv-maternal" hreflang="en">Novavax Announces Presentation of Phase 3 Data from RSV Maternal Immunization Program at 37th Annual Meeting of the European Society for Pediatric Infectious Diseases</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 01, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced that Flor M. Muñoz, M.D., M.Sc., Associate Professor of Pediatrics Molecular Virology and Microbiology at Baylor College of Medicine and Medical Director, Transplant Infectious Diseases, Texas...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 25, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-first-quarter-financial-2" hreflang="en">Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 2, 2019</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 25, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2019 financial and operating results following the close of U.S. financial markets on Thursday, May 2, 2019 . Conference call details are as follows: Date: ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 09, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-scientific-leadership-present-rsv-maternal-immunization" hreflang="en">Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 09, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced that Gregory M. Glenn , M.D., President of Research and Development, will share data from its global Phase 3 clinical trial of ResVax™, the respiratory syncytial virus (RSV) fusion (F) protein...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 18, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-year-end-2018-financial" hreflang="en">Novavax Reports Fourth Quarter and Year-End 2018 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md. , March 18, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and twelve months ended December 31, 2018 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 11, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-fourth-quarter-and-year-end" hreflang="en">Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 18, 2019</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , March 11, 2019 (GLOBE NEWSWIRE) --Novavax, Inc. (Nasdaq: NVAX) today announced it will report its fourth quarter and year-end 2018 financial and operating results following the close of U.S. financial markets on Monday, March 18, 2019....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 28, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-topline-results-phase-3-preparetm-trial" hreflang="en">Novavax Announces Topline Results from Phase 3 PrepareTM Trial of ResVax™ for Prevention of RSV Disease in Infants via Maternal Immunization</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Trial did not meet primary objective of prevention of medically significant RSV LRTI Trial did show efficacy against secondary objective (RSV LRTI hospitalization); first RSV vaccine to show Phase 3 efficacy Other pre-specified exploratory endpoints and post-hoc analyses highlight potential to...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 03, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-phase-2-nanoflu-results-older-adults" hreflang="en">Novavax Announces Positive Phase 2 NanoFlu Results in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Sets the Stage for Phase 3 Clinical Trial in 2019 Phase 2 clinical trial confirmed Phase 1/2 results, again demonstrating improved immune responses over Fluzone ® High-Dose End-of-Phase 2 meeting with the FDA expected in the first half of 2019 Pivotal Phase 3 clinical trial expected to initiate in...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 02, 2019 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-37th-annual-jp-morgan-healthcare-conference" hreflang="en">Novavax to Present at the 37th Annual J.P. Morgan Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 02, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will present at the 37th Annual J.P. Morgan Healthcare Conference . Presentation details are as follows: Date and time: Wednesday, January 9 , 3:00 p.m. – 3:25 p.m. P.T....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 04, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-leadership-promotions" hreflang="en">Novavax Announces Leadership Promotions</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Dec. 04, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced the promotion of Jill Hoyt to Senior Vice President of Human Resources and Biegie Lee to Vice President of Information Technology. “I am thrilled to announce these two important management promotions;...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 12, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-expands-leadership-several-key-management-promotions" hreflang="en">Novavax Expands Leadership with Several Key Management Promotions</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 12, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced several management promotions. “We are pleased to announce several key management promotions to further support the advancement of our company and its lead clinical programs into commercial stage,&quot;...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 07, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2018-financial-results" hreflang="en">Novavax Reports Third Quarter 2018 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md. , Nov. 07, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter and nine months ended September 30, 2018 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 01, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-third-quarter-financial-1" hreflang="en">Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its third quarter 2018 financial and operating results following the close of U.S. financial markets on Wednesday, November 7, 2018 . Conference call details are as follows: Date: ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 01, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-rachel-king-board-directors" hreflang="en">Novavax Appoints Rachel King to Board of Directors</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq: NVAX) today announced the appointment of Rachel King , Co-Founder and Chief Executive Officer of GlycoMimetics, Inc. , to its Board of Directors. In addition to extensive experience as an executive in the biotechnology...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 02, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-highlight-rsv-program-data-two-upcoming-meetings" hreflang="en">Novavax to Highlight RSV Program Data at Two Upcoming Meetings</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 02, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced that its representatives will share data from its RSV F vaccine program via oral and poster presentations at IDWeek 2018 in San Francisco, California , taking place October 3-7 and at the 11th...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 26, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-two-upcoming-investor-conferences" hreflang="en">Novavax to Present at Two Upcoming Investor Conferences</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 26, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced that it will present at the Ladenburg Thalmann 2018 Healthcare Conference and the Cantor Global Healthcare Conference 2018, both in the first week of October....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 25, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-2-clinical-trial-nanoflutm-older-adults" hreflang="en">Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>First participants enrolled in Phase 2 clinical trial of quadrivalent NanoFlu formulations Top-line immunogenicity and safety data expected in the first quarter of 2019 Phase 2 results will support meeting with the U.S. Food and Drug Administration ( FDA ) and Phase 3 clinical trial design...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 28, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-participate-two-upcoming-investor-conferences" hreflang="en">Novavax to Participate at Two Upcoming Investor Conferences</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 28, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced that Novavax will participate in the B. Riley FBR Annual Healthcare Conference and the Citi 13 th Annual Biotech Conference in September. Conference details are as follows: B....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 08, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-second-quarter-2018-financial-results" hreflang="en">Novavax Reports Second Quarter 2018 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Novavax Delivers on Key Milestones Supporting its 2018 Objectives Company to Host Conference Call Today at 4:30 pm ET GAITHERSBURG, Md. , Aug. 08, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the second quarter and six ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 01, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-second-quarter-financial-1" hreflang="en">Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 8, 2018</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter 2018 financial and operating results following the close of U.S. financial markets on Wednesday, August 8, 2018 . Conference call details are as follows: Date: August...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 13, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/new-england-journal-medicine-publishes-novavax-nanoflu-clinical" hreflang="en">New England Journal of Medicine Publishes Novavax’ NanoFlu Clinical Trial Data</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NanoFlu TM Phase 1/2 trial data published in a peer-reviewed letter to the editor in The New England Journal of Medicine NanoFlu demonstrates significantly improved immune responses against a panel of homologous and drifted A(H3N2) influenza viruses compared to leading licensed egg-based, high-dose ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 31, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-discuss-future-global-vaccine-business-part-panel" hreflang="en">Novavax CEO to Discuss Future of Global Vaccine Business as Part of Panel of Industry Leaders at 2018 BIO International Convention</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Title: “The Global Vaccine Business: A View from the Top” Date and Time: Tuesday, June 5, 12:15 p.m. Moderator: Jacqueline Keith, MA, PhD, President, J Keith Consulting Group Panelists: Stanley Erck, President and Chief Executive Officer, Novavax David Loew, Head, Global Commercial Operations,...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 09, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2018-financial-results" hreflang="en">Novavax Reports First Quarter 2018 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 09, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced its financial results for the first quarter ended March 31, 2018 . First Quarter and Subsequent Achievements: RSV F Vaccine In May 2018 , Novavax reached enrollment of approximately 4,600 pregnant ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 07, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reaches-significant-enrollment-milestone-preparetm-phase" hreflang="en">Novavax Reaches Significant Enrollment Milestone in the Prepare(TM) Phase 3 Trial of its RSV F Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Prepare trial is assessing the efficacy of Novavax’ RSV F Vaccine for infants via maternal immunization Enrollment of ~4,600 participants enables initiation of interim efficacy analysis Topline efficacy data from analysis expected in the first quarter of 2019 GAITHERSBURG, Md. ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 02, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-first-quarter-financial-1" hreflang="en">Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 9, 2018</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 02, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its first quarter 2018 financial and operating results following the close of U.S. financial markets on Wednesday, May 9, 2018 . Conference call details are as follows: Date: May 9, ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 16, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-closing-public-offering-0" hreflang="en">Novavax Announces Closing of Public Offering</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 16, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced the closing of the underwritten public offering priced on Wednesday, April 11, 2018 . ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 11, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-prices-public-offering-common-stock-2" hreflang="en">Novavax Prices Public Offering of Common Stock</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 11, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced that it has priced an underwritten public offering of 30,303,050 shares of common stock ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 11, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-proposed-public-offering-common-stock-1" hreflang="en">Novavax Announces Proposed Public Offering of Common Stock</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 11, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases, today announced that it intends to offer to sell, subject to market and other conditions, shares of its ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 02, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-clinical-data-rsv-f-and-nanoflutm-vaccines-world" hreflang="en">Novavax to Present Clinical Data on RSV F and NanoFlu™ Vaccines at World Vaccine Congress</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Update on RSV F Vaccine Phase 3 Prepare ™ trial for infants via maternal immunization Results from Phase 1/2 trial of NanoFlu vaccine demonstrating improved immune responses compared to egg-based, high-dose flu vaccine GAITHERSBURG, Md. , April 02, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. ...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 14, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-provides-corporate-update-and-report-fourth-quarter-and" hreflang="en">Novavax Provides Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>RSV Phase 3 Prepare™ Trial Outcome De-risked by Successful Informational Analysis NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine John J. Trizzino Appointed Chief Business Officer and Chief Financial Officer (as Announced in Separate Press...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 14, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-promotes-john-j-trizzino-expanded-role-chief-business" hreflang="en">Novavax Promotes John J. Trizzino to Expanded Role as Chief Business Officer and Chief Financial Officer</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Gaithersburg, MD, March 14, 2018 – Novavax, Inc., (Nasdaq: NVAX) today announced the promotion of John J. Trizzino to Senior Vice President, Chief Business Officer (CBO) and Chief Financial Officer (CFO). Mr. Trizzino has been serving as Senior Vice President, Commercial Operations, since 2014....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li class="has-news-supp"> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 07, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-and-webcast-provide-corporate" hreflang="en">Novavax to Host Conference Call and Webcast to Provide Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Gaithersburg, MD, March 7, 2018 -- Novavax, Inc. (Nasdaq:NVAX) today announced it will provide a corporate update and report its fourth quarter and full year 2017 financial and operating results following the close of U.S. financial markets on Wednesday, March 14, 2018....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> <div class="col"> <div class="views-field views-field-field-nir-news-supp-format"><div class="field-content"> <article role="article" class="node node--nir-asset--asset-link node--type-nir-asset node--view-mode-asset-link"> <div class="node__content"> <div class="field field--name-field-nir-document field--type-file field--label-hidden field__items"> <div class="field__item"> <div class="file-link"> <span class="file file--mime-application-pdf file--application-pdf"> <a href="https://ir.novavax.com/static-files/43420448-9e22-4a2d-8464-b51cfc363e49" type="application/pdf; length=36122" title="Novavax_to_Host_4Q_call.pdf">Download PDF</a></span><span class="filesize"> 36.1 KB</span> </div> </div> </div> </div> </article> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 28, 2018 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-nanoflutm-vaccine-demonstrates-improved-immune-responses" hreflang="en">Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 18, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-continues-phase-3-trial-rsv-f-vaccine-infants-maternal" hreflang="en">Novavax Continues Phase 3 Trial of the RSV F Vaccine for Infants via Maternal Immunization and Provides Update on Phase 1/2 Trial of the NanoFlu™ Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>RSV F Vaccine informational analysis completed in fourth quarter of 2017 RSV F Vaccine interim analysis expected mid-2018 with approximately 4,600 enrollees Filing of RSV F Vaccine BLA anticipated by late 2019 NanoFlu Vaccine data package to be completed and released in February 2018 GAITHERSBURG,...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 08, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-stifel-2017-healthcare-conference" hreflang="en">Novavax to Present at the Stifel 2017 Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 08, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced the Company will present at the Stifel 2017 Healthcare Conference. Presentation details are as follows: Date: Wednesday, November 15, 2017 Time: 1:15 p.m. – 1:55 p.m....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 07, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2017-financial-results" hreflang="en">Novavax Reports Third Quarter 2017 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced its financial results for the third quarter and nine months ended September 30, 2017 . Third Quarter Achievements: Novavax initiated a Phase 1/2 clinical trial of its nanoparticle influenza vaccine...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 31, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-third-quarter-2017" hreflang="en">Novavax to Host Conference Call to Discuss Third Quarter 2017 Financial Results on November 7, 2017</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 31, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its third quarter financial and operating results following the close of U.S. financial markets on Tuesday, November 7, 2017 . Conference call details are as follows: Date: Tuesday,...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 13, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-leadership-change" hreflang="en">Novavax Announces Leadership Change</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 13, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) announced today that Barclay A. “Buck” Phillips has submitted his resignation as Senior Vice President, Chief Financial Officer (CFO) and Treasurer, to pursue an expanded opportunity in the industry. Mr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 19, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-ladenburg-thalmann-2017-healthcare-conference" hreflang="en">Novavax to Present at the Ladenburg Thalmann 2017 Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 19, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced the Company will present at the Ladenburg Thalmann 2017 Healthcare Conference. Presentation details are as follows: Date: Tuesday, September 26, 2017 Time: 11:00 – 11:25 am ET Location: Track 5,...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 19, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-12-trial-nanoflutm-vaccine-older-adults" hreflang="en">Novavax Initiates Phase 1/2 Trial of NanoFlu™ Vaccine in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Recently published NanoFlu™ preclinical data provide strong rationale for Phase 1/2 clinical trial based on robust antibody titers and improved protective responses against both current and drifted strains Data from trial expected by the end of 2017 GAITHERSBURG, Md. , Sept....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 05, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-participate-citi-12th-annual-biotech-conference" hreflang="en">Novavax to Participate in the Citi 12th Annual Biotech Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 05, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced the Company will participate in Citi’s 12 th Annual Biotech Conference . Conference details are as follows: Date: Thursday, September 7, 2017 Location: Mandarin Oriental hotel, Boston, MA About...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 23, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-preclinical-influenza-nanoparticle-study-published" hreflang="en">Novavax’ Preclinical Influenza Nanoparticle Study Published in Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Novel vaccine candidate, NanoFlu™, outperforms market-leading Fluzone® High Dose based on antibody titers and neutralization of recent and historic influenza viruses in a preclinical study GAITHERSBURG, Md. , Aug. 23, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 08, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-second-quarter-2017-financial-results" hreflang="en">Novavax Reports Second Quarter 2017 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 08, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2017 . Second Quarter and Subsequent Achievements: Novavax’ nanoparticle flu vaccine demonstrates superior immunogenicity and...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 01, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-second-quarter-2017" hreflang="en">Novavax to Host Conference Call to Discuss Second Quarter 2017 Financial Results on August 8, 2017</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Novavax to Host Conference Call to Discuss Second Quarter 2017 Financial Results on August 8, 2017 Gaithersburg, MD, August 1, 2017 -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its second quarter financial and operating results following the close of U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 24, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-topline-data-phase-2-older-adult" hreflang="en">Novavax Announces Positive Topline Data from Phase 2 Older Adult Trial and Provides Path Forward for RSV F Vaccine Programs</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Phase 2 data in older adults (E205) demonstrate adjuvants and 2-dose regimens significantly increase the magnitude, duration and quality of the RSV F Vaccine immune response New data demonstrate that Novavax’ construct is a stable prefusogenic RSV F antigen, distinctive from other candidates,...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 21, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/reminder-novavax-host-rsv-f-vaccine-update-conference-call-and" hreflang="en">Reminder: Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4:30 PM</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>-- Announce topline data from the Phase 2 Safety and Immunogenicity trial of the RSV F Vaccine in older adults -- Provide an Update on the RSV F Vaccine Development Program GAITHERSBURG, Md. , July 21, 2017 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will host a conference call...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 17, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-rsv-f-vaccine-update-conference-call-and-webcast" hreflang="en">Novavax to Host an RSV F Vaccine Update Conference Call and Webcast on July 24, 2017 at 4:30 PM</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- Announce topline data from the Phase 2 Safety and Immunogenicity trial of the RSV F Vaccine in older adults - Provide an Update on the RSV F Vaccine Development Program GAITHERSBURG, Md. , July 17, 2017 /PRNewswire/ -- Novavax, Inc. (Nasdaq:NVAX) today announced it will host a conference call...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 07, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-rsv-f-vaccine-phase-2-clinical-trial-data-women-child" hreflang="en">Novavax RSV F Vaccine Phase 2 Clinical Trial Data in Women of Child Bearing Age Published in Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Trial demonstrated a reduction of RSV infection in vaccinated women of greater than 50%, suggesting potential benefits to the mother, pregnancy outcomes and her infant GAITHERSBURG, Md. , June 7, 2017 /PRNewswire/ -- Novavax, Inc., (Nasdaq:NVAX) today announced that data from the second of two...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 11, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-promotion-dr-james-f-cummings-vice-president" hreflang="en">Novavax Announces the Promotion of Dr. James F. Cummings to Vice President, Clinical Development and Translational Medicine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 11, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), today announced that Dr. James F. Cummings has been promoted to Vice President, Clinical Development and Translational Medicine. Dr. Cummings joined Novavax as Senior Director of Clinical Development in September 2015...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 08, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2017-financial-results" hreflang="en">Novavax Reports First Quarter 2017 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 08, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced its financial results for the first quarter ended March 31, 2017 . First Quarter Achievements: Enrollment continued during the second global season in the RSV Phase 3 Prepare™ clinical trial for...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 01, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-first-quarter-2017" hreflang="en">Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 01, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its first quarter 2017 financial and operating results following the close of U.S. financial markets on Monday, May 8, 2017 . Conference call details are as follows: Date: Monday,...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 27, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-year-end-2016-financial-0" hreflang="en">Novavax Reports Fourth Quarter and Year-End 2016 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Feb. 27, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced its financial results for the fourth quarter and twelve months ended December 31, 2016 . Recent and Fourth Quarter Achievements: Continued execution of the global Phase 3 Prepare™ clinical trial to...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 20, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-fourth-quarter-and-year-0" hreflang="en">Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Feb. 20, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its fourth quarter and full year 2016 financial and operating results following the close of U.S. financial markets on Monday, February 27, 2017 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 19, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-2-safety-and-immunogenicity-trial-rsv-f" hreflang="en">Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 19, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced the initiation of a Phase 2 clinical trial of its respiratory syncytial virus F-protein nanoparticle vaccine candidate (RSV F Vaccine) in older adults (60 years of age and older)....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 05, 2017 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-35th-annual-jp-morgan-healthcare-conference" hreflang="en">Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 05, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that management will present at the 35 th Annual J.P. Morgan Healthcare Conference . Presentation details are as follows: Date: Thursday, January 12, 2017 Time: 9:30 am U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 06, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-participate-4th-annual-guggenheim-boston-healthcare" hreflang="en">Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Dec. 06, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced the Company will participate in the 4 th Annual Guggenheim Boston Healthcare Conference ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 30, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-participate-citi-2016-global-healthcare-conference" hreflang="en">Novavax to Participate in the Citi 2016 Global Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 30, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced the Company will participate in the Citi 2016 Global Healthcare Conference....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 22, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-28th-annual-piper-jaffray-healthcare-conference" hreflang="en">Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 22, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced Stanley C Erck, President and Chief Executive Officer, will present at the 28 th Annual Piper Jaffray Healthcare Conference ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 09, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2016-financial-results" hreflang="en">Novavax Reports Third Quarter 2016 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Announces Corporate Restructuring and Cost Savings Highlights Strategic Focus and Development Activities for 2017 GAITHERSBURG, Md. , Nov. 09, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 02, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/update-novavax-host-conference-call-discuss-third-quarter" hreflang="en">UPDATE -- Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Financial results conference call will include Investor and Analyst webcast presentation GAITHERSBURG, Md. , Nov. 02, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 02, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-third-quarter-financial-0" hreflang="en">Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Financial results conference call will include Investor and Analyst webcast presentation GAITHERSBURG, Md. , Nov. 02, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 07, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reschedules-4th-annual-investor-and-analyst-meeting" hreflang="en">Novavax Reschedules 4th Annual Investor and Analyst Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 07, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced it has rescheduled its 4th annual Investor and Analyst Meeting....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 04, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-4th-annual-investor-and-analyst-meeting-0" hreflang="en">Novavax to Host 4th Annual Investor and Analyst Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 04, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced it will host its 4th annual Investor and Analyst Meeting, Tuesday, October 11, 2016 from 9:00 a.m. – 11:00 a.m. ET in New York, NY ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 15, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-topline-rsv-f-vaccine-data-two-clinical-trials" hreflang="en">Novavax Announces Topline RSV F Vaccine Data from Two Clinical Trials in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Topline data from the Resolve™ Phase 3 trial did not meet pre-specified efficacy objectives The attack rate for the Phase 3 primary objective was approximately 25% of that observed in Phase 2 trial Topline data from our Phase 2 rollover trial suggest improved vaccine efficacy from a second year of...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 07, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-4th-annual-investor-and-analyst-meeting" hreflang="en">Novavax to Host 4th Annual Investor and Analyst Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 07, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced it will host its 4th annual Investor and Analyst Meeting, Tuesday, October 11, 2016 from 9:00 a.m. – 11:00 a.m. ET in New York, NY ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 09, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-second-quarter-2016-financial-results" hreflang="en">Novavax Reports Second Quarter 2016 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 09, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2016 . Novavax Second Quarter Achievements: Announced a new seasonal combination respiratory vaccine program....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 02, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-second-quarter-financial-0" hreflang="en">Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 9, 2016</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 02, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 17, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-recognized-washington-post-top-workplace-0" hreflang="en">Novavax Recognized by Washington Post as Top Workplace</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>(GLOBE NEWSWIRE via COMTEX) --GAITHERSBURG, Md., June 17, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), today announced that, for the third consecutive year, it has been recognized as a Top Workplace for 2016....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 02, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-new-seasonal-combination-respiratory-vaccine" hreflang="en">Novavax Announces New Seasonal Combination Respiratory Vaccine Program</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Seasonal influenza nanoparticle approach replaces VLP program HHS BARDA contract will complete its term as scheduled in September 2016 Nanoparticle design builds on advances achieved with RSV F Vaccine Animal immunogenicity and efficacy data demonstrate broadly neutralizing antibodies Data presented...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 25, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/us-fda-grants-fast-track-designation-novavax-rsv-f-vaccine-older" hreflang="en">U.S. FDA Grants Fast Track Designation to Novavax’ RSV F Vaccine for Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 25, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 12, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-receives-tech-council-marylands-chairmans-award" hreflang="en">Novavax Receives the Tech Council of Maryland’s Chairman’s Award</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 12, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 11, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-participate-2016-citi-midwest-healthcare-access-day" hreflang="en">Novavax to Participate in the 2016 Citi Midwest Healthcare Access Day</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 11, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 04, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2016-financial-results" hreflang="en">Novavax Reports First Quarter 2016 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 04, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 27, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-first-quarter-financial-0" hreflang="en">Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 4, 2016</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 27, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 13, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-participate-fbr-new-prescriptions-conference" hreflang="en">Novavax to Participate in the FBR New Prescriptions Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 13, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 06, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-15th-annual-needham-healthcare-conference" hreflang="en">Novavax to Present at the 15th Annual Needham Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 06, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 04, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-management-promotion-2" hreflang="en">Novavax Announces Management Promotion</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 04, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 17, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-bob-darius-senior-vice-president-quality" hreflang="en">Novavax Appoints Bob Darius Senior Vice President, Quality Operations</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , March 17, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 29, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-year-end-2015-financial" hreflang="en">Novavax Reports Fourth Quarter and Year-End 2015 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Feb. 29, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 22, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-fourth-quarter-and-full-0" hreflang="en">Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Feb. 22, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 05, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-exercise-over-allotment-option-purchase" hreflang="en">Novavax Announces Exercise of Over-Allotment Option to Purchase Additional Shares</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Feb. 05, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 29, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-closing-300-million-offering-convertible" hreflang="en">Novavax Announces Closing of $300 Million Offering of Convertible Senior Notes Due 2023</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 29, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 25, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-prices-300-million-convertible-senior-notes-due-2023" hreflang="en">Novavax Prices $300 Million of Convertible Senior Notes Due 2023</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 25, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 25, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-proposed-offering-200-million-convertible" hreflang="en">Novavax Announces Proposed Offering of $200 Million of Convertible Senior Notes Due 2023</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 25, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 08, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-jeffrey-stoddard-md-vice-president-medical" hreflang="en">Novavax Appoints Jeffrey Stoddard, M.D., Vice President, Medical Affairs</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 08, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 06, 2016 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-34th-annual-jp-morgan-healthcare-conference" hreflang="en">Novavax to Present at the 34th Annual J.P. Morgan Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 06, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that management will present at the 34 th Annual J.P....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 21, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-mark-twyman-vice-president-marketing" hreflang="en">Novavax Appoints Mark Twyman Vice President Marketing</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Dec. 21, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 14, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-completes-enrollment-pivotal-phase-3-trial-rsv-f-vaccine" hreflang="en">Novavax Completes Enrollment of Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Dec. 14, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 08, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-participate-guggenheim-securities-3rd-annual-boston" hreflang="en">Novavax to Participate in the Guggenheim Securities 3rd Annual Boston Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Dec. 08, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 03, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-global-pivotal-phase-3-trial-rsv-f-vaccine" hreflang="en">Novavax Initiates Global Pivotal Phase 3 Trial of the RSV F Vaccine to Protect Infants via Maternal Immunization</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Dec. 03, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 24, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-27th-annual-piper-jaffray-healthcare-conference" hreflang="en">Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 24, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 16, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-make-multiple-presentations-rsv-vaccines-world" hreflang="en">Novavax to Make Multiple Presentations at RSV Vaccines for the World</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Conference Will Take Place November 18-20, 2015 in La Jolla, California GAITHERSBURG, Md. , Nov. 16, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 10, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-stifel-2015-healthcare-conference" hreflang="en">Novavax to Present at the Stifel 2015 Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 10, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 09, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2015-financial-results" hreflang="en">Novavax Reports Third Quarter 2015 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 09, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 09, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-pivotal-phase-3-trial-rsv-f-vaccine-older" hreflang="en">Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 09, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 02, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-third-quarter-financial" hreflang="en">Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2015</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 02, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 22, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-2-safety-and-immunogenicity-trial" hreflang="en">Novavax Initiates Phase 2 Safety and Immunogenicity Trial to Evaluate Annual Re-Dosing of the RSV F Vaccine in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 22, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 01, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-management-promotion-1" hreflang="en">Novavax Announces Management Promotion</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 01, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 29, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-top-line-data-rsv-f-vaccine-phase-1" hreflang="en">Novavax Announces Positive Top-Line Data From RSV F Vaccine Phase 1 Clinical Trial in Pediatrics</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Novavax’ Fifth Positive Top-Line Clinical Trial Announcement of the 3rd Quarter GAITHERSBURG, Md. , Sept. 29, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 29, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-3rd-annual-analyst-and-investor-meeting-0" hreflang="en">Novavax to Host 3rd Annual Analyst and Investor Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md., Sept....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 29, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-top-line-data-phase-2-clinical-trial" hreflang="en">Novavax Announces Positive Top-Line Data from Phase 2 Clinical Trial of RSV F Vaccine to Protect Infants via Maternal Immunization</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>-RSV F Vaccine was safe and well-tolerated -Significant anti-F, PCA and microneutralizing antibody responses elicited in mothers -Efficient antibody transfer from mothers to infants observed -Results suggest potential to protect infants when they are most at risk GAITHERSBURG, Md. , Sept....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 29, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-grant-89-million-support-development-rsv-f" hreflang="en">Novavax Announces Grant of Up to $89 Million to Support Development of RSV F Vaccine to Protect Infants Via Maternal Immunization</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Bill &amp;amp; Melinda Gates Foundation to Support Development of the RSV F Vaccine Program GAITHERSBURG, Md. , Sept. 29, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 21, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-ladenburg-thalmann-2015-healthcare-conference" hreflang="en">Novavax to Present at the Ladenburg Thalmann 2015 Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 21, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 15, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-rsv-f-vaccine-highly-immunogenic-robust-transplacental" hreflang="en">Novavax RSV F Vaccine is Highly Immunogenic With Robust Transplacental Antibody Transfer in Preclinical Maternal Immunization Model</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 15, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 10, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-rsv-f-vaccine-clinical-trial-data-women-child-bearing" hreflang="en">Novavax RSV F Vaccine Clinical Trial Data in Women of Child Bearing Age Published in the Journal of Infectious Disease</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 10, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 02, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-participate-multiple-investor-conferences-september" hreflang="en">Novavax to Participate in Multiple Investor Conferences in September</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 02, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 26, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-3rd-annual-analyst-and-investor-meeting" hreflang="en">Novavax to Host 3rd Annual Analyst and Investor Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 26, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 10, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-top-line-data-phase-2-rsv-f-protein" hreflang="en">Novavax Announces Positive Top-Line Data from Phase 2 RSV F-Protein Vaccine Clinical Trial in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- First respiratory syncytial virus (RSV) vaccine to demonstrate efficacy in any population - Statistically significant vaccine efficacy in prevention of symptomatic RSV disease in older adults - Large prospective epidemiological study of RSV; detected a seasonal attack rate of 4.9% for symptomatic...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 10, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-second-quarter-2015-financial-results" hreflang="en">Novavax Reports Second Quarter 2015 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 10, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 05, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-wedbush-pacgrow-healthcare-conference" hreflang="en">Novavax to Present at the Wedbush PacGrow Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 05, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 03, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-second-quarter-financial" hreflang="en">Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 10, 2015</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 03, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 30, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-data-phase-2-trial-quadrivalent" hreflang="en">Novavax Announces Positive Data From Phase 2 Trial of Quadrivalent Seasonal Influenza VLP</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , July 30, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 21, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-top-line-data-phase-1-ebola-vaccine" hreflang="en">Novavax Announces Positive Top-Line Data From Phase 1 Ebola Vaccine Trial on WHO Teleconference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , July 21, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 19, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-recognized-washington-post-top-workplace" hreflang="en">Novavax Recognized by Washington Post as Top Workplace</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 19, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 18, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-gail-boudreaux-board" hreflang="en">Novavax Appoints Gail Boudreaux to Board</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 18, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced the appointment of Gail K....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 15, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-management-promotion-0" hreflang="en">Novavax Announces Management Promotion</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 15, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 07, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2015-financial-results" hreflang="en">Novavax Reports First Quarter 2015 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 7, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced its financial results for the first quarter 2015....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 30, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-first-quarter-financial" hreflang="en">Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 7, 2015</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 30, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 08, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-14th-annual-needham-healthcare-conference" hreflang="en">Novavax to Present at the 14th Annual Needham Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 8, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. , (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 31, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-closing-public-offering" hreflang="en">Novavax Announces Closing of Public Offering</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , March 31, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 28, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-presents-new-data-non-human-primate-ebola-challenge-7th" hreflang="en">Novavax Presents New Data From Non-Human Primate Ebola Challenge at the 7th International Symposium on Filoviruses</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , March 28, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 26, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-prices-public-offering-common-stock-1" hreflang="en">Novavax Prices Public Offering of Common Stock</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , March 26, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 24, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-proposed-public-offering-common-stock-0" hreflang="en">Novavax Announces Proposed Public Offering of Common Stock</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , March 24, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 10, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-brian-rosen-vice-president-government-affairs" hreflang="en">Novavax Appoints Brian Rosen as Vice President, Government Affairs</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , March 10, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 26, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-year-end-2014-financial" hreflang="en">Novavax Reports Fourth Quarter and Year-End 2014 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Feb. 26, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 19, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-fourth-quarter-and-full" hreflang="en">Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Feb. 19, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 12, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-initiation-ebola-vaccine-phase-1-clinical" hreflang="en">Novavax Announces Initiation of Ebola Vaccine Phase 1 Clinical Trial Supported by Non-Human Primate Challenge Data and Documented Rapid Manufacturing Capabilities</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Initiation of Enrollment of Phase 1 Clinical Trial of Ebola GP Vaccine Non-Human Primate Challenge Data Signal Breakthrough in Ebola Vaccine Development Rapid Manufacturing Process of Ebola GP Vaccine Published in BioProcessing Journal GAITHERSBURG, Md. , Feb....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 08, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-management-promotion" hreflang="en">Novavax Announces Management Promotion</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 8, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that Jill Hoyt has been named Vice President, Human Resources &amp;amp; Administration. Ms....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 07, 2015 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-33rd-annual-jp-morgan-healthcare-conference" hreflang="en">Novavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Jan. 7, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 26, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-26th-annual-piper-jaffray-healthcare-conference" hreflang="en">Novavax to Present at the 26th Annual Piper Jaffray Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 26, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants , today announced that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 20, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/us-fda-grants-fast-track-designation-novavax-rsv-f-protein" hreflang="en">U.S. FDA Grants Fast Track Designation to Novavax&#039; RSV F-Protein Nanoparticle Vaccine for Protection of Infants Via Maternal Immunization</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 20, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 17, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-2-clinical-trial-quadrivalent-seasonal" hreflang="en">Novavax Initiates Phase 2 Clinical Trial of Quadrivalent Seasonal Influenza VLP</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 17, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 13, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-jefferies-global-healthcare-conference" hreflang="en">Novavax to Present at the Jefferies Global Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 13, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 10, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-1-clinical-trial-rsv-f-vaccine-pediatric" hreflang="en">Novavax Initiates Phase 1 Clinical Trial of RSV F Vaccine in Pediatric Subjects</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 10, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 06, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-collaborators-make-multiple-presentations-9th" hreflang="en">Novavax and Collaborators Make Multiple Presentations at the 9th International Respiratory Syncytial Virus Symposium in South Africa, November 9-13, 2014</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 6, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 05, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2014-financial-results" hreflang="en">Novavax Reports Third Quarter 2014 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Nov. 5, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 30, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-third-quarter-2014" hreflang="en">Novavax to Host Conference Call to Discuss Third Quarter 2014 Financial Results on November 5, 2014</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 30, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 29, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/us-fda-grants-fast-track-designation-novavax-h7n9-influenza" hreflang="en">U.S. FDA Grants Fast Track Designation to Novavax&#039; H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M(TM)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 29, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that the U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 27, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-ebola-vaccine-development-program-8th-vaccine" hreflang="en">Novavax Announces Ebola Vaccine Development Program at the 8th Vaccine and ISV Conference in Philadelphia</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>First Ebola Vaccine Candidate based on the 2014 Guinea Ebola Strain Genetic Sequence Robust immune responses demonstrated in preclinical studies; exceptional responses when used with Novavax &#039; Matrix-M™ adjuvant Non-human primate study initiated GMP manufacture initiated; Scaled-up manufacturing to...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 26, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-presents-rsv-f-protein-nanoparticle-vaccine-clinical" hreflang="en">Novavax Presents RSV F Protein Nanoparticle Vaccine Clinical Data at the 8th Vaccine &amp; ISV Congress in Philadelphia on Sunday, October 26</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 26, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 23, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-rsv-vaccine-clinical-data-8th-vaccine-isv" hreflang="en">Novavax to Present RSV Vaccine Clinical Data at the 8th Vaccine &amp; ISV Congress in Philadelphia on Sunday, October 26</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 23, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 15, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-study-published-vaccine-rsv-f-protein-nanoparticle" hreflang="en">Novavax Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Antibodies</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Vaccinated Animals Generated a Broad Spectrum of Protective Antibodies Vaccine Induces Antibodies that are at Least as Protective as Palivizumab Palivizumab Competing Antibody Response from Vaccine Protects Against Both Homologous and Heterologous Disease Strains GAITHERSBURG, Md. , Oct....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 14, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-2-clinical-trial-rsv-vaccine-elderly" hreflang="en">Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine in Elderly Subjects</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Oct. 14, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 23, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-barda-exercise-contract-option" hreflang="en">Novavax Announces BARDA Exercise of Contract Option</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Award of Option Period for 24 months Additional Option Period Funding Commitment of $70 million Clinical, Manufacturing and Product Development Activities Funded Up to Phase 3 GAITHERSBURG, Md. , Sept. 23, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 23, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-h7n9-avian-influenza-vlp-vaccine-candidate-matrix-mtm" hreflang="en">Novavax&#039; H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM) Delivers Positive Phase 1/2 Clinical Data</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Vaccine and adjuvant were well-tolerated, consistent with the company&#039;s prior studies with saponin-based adjuvants Hemagglutination-inhibiting antibody responses similar to prior Novavax studies of A(H7N9) with another saponin adjuvant Strong neuraminidase inhibiting antibody responses in adjuvanted...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 16, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-2-clinical-trial-rsv-f-protein" hreflang="en">Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy Third-Trimester Pregnant Women</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 16, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 11, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-2nd-annual-analyst-and-investor-meeting" hreflang="en">Novavax to Host 2nd Annual Analyst and Investor Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 11, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 08, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/icaac-presentation-immunization-pregnant-baboons-rsv-f" hreflang="en">ICAAC Presentation: Immunization of Pregnant Baboons With the RSV F Nanoparticle Vaccine Protects Infant Baboons Challenged With Respiratory Syncytial Virus in a Comparable Manner to Infants Prophylaxed With Palivizumab</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Immunization of pregnant baboons generates anti-F IgG antibodies that are transferred from mothers to their infants When challenged with RSV, infant baboons born to immunized mothers show equivalent protection to infant baboons receiving palivizumab (Synagis ®) therapy GAITHERSBURG, Md. , Sept....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 06, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-presents-data-rsv-f-nanoparticle-vaccine-induced" hreflang="en">Novavax Presents Data on RSV F Nanoparticle Vaccine Induced Monoclonal Antibody at ICAAC</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 6, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 03, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/correcting-and-replacing-novavax-present-rsv-vaccine-preclinical" hreflang="en">CORRECTING and REPLACING -- Novavax to Present RSV Vaccine Preclinical Results at ICAAC</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 3, 2014 (GLOBE NEWSWIRE) -- In a release issued earlier today by Novavax, Inc. (Nasdaq:NVAX), the headline read &quot; Novavax to Present RSV Vaccine Clinical and Preclinical Results at ICAAC&quot;....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 03, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-rsv-vaccine-clinical-and-preclinical-results-0" hreflang="en">Novavax to Present RSV Vaccine Clinical and Preclinical Results at ICAAC</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Sept. 3, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 07, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-wedbush-securities-life-sciences-management" hreflang="en">Novavax to Present at the Wedbush Securities Life Sciences Management Access Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 7, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 06, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-second-quarter-2014-financial-results" hreflang="en">Novavax Reports Second-Quarter 2014 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Aug. 6, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 30, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-conference-call-discuss-second-quarter-2014" hreflang="en">Novavax to Host Conference Call to Discuss Second Quarter 2014 Financial Results on August 6, 2014</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , July 30, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 23, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-recognized-one-washington-posts-top-workplaces" hreflang="en">Novavax Recognized as One of The Washington Post&#039;s Top Workplaces</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 23, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 19, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-management-promotions" hreflang="en">Novavax Announces Management Promotions</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 19, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 18, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/long-time-novavax-board-member-jack-marsh-assumes-role-director" hreflang="en">Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 18, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that on June 12, 2014 , the Honorable John O....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 11, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-exercise-option-purchase-additional-shares-and" hreflang="en">Novavax Announces Exercise of Option to Purchase Additional Shares and Closing of Public Offering</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 11, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 05, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-prices-public-offering-common-stock-0" hreflang="en">Novavax Prices Public Offering of Common Stock</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 5, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 04, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-proposed-public-offering-common-stock" hreflang="en">Novavax Announces Proposed Public Offering of Common Stock</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 4, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 02, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-jefferies-2014-global-healthcare-conference" hreflang="en">Novavax to Present at the Jefferies 2014 Global Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , June 2, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 12, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/one-year-follow-rsv-f-protein-vaccine-candidate-phase-1-elderly" hreflang="en">One Year Follow-Up From RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial Demonstrates Sustained Levels of Immune Response</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Sustained levels of RSV F antibody and palivizumab-competing antibody responses demonstrated over a 4 to 6 month period Results support accelerating development plans for &quot;seasonal&quot; elderly RSV vaccine Phase 2 clinical trial in elderly anticipated to start in late-2014/early-2015 GAITHERSBURG, Md....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 07, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2014-financial-results" hreflang="en">Novavax Reports First-Quarter 2014 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 7, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 06, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-sven-andreasson-senior-vice-president-corporate" hreflang="en">Novavax Appoints Sven Andreasson as Senior Vice President, Corporate Development</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 6, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 01, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-first-quarter-financial-results-may-7-2014" hreflang="en">Novavax to Report First Quarter Financial Results on May 7, 2014</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , May 1, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it will report its first quarter 2014 financial results on Wednesday, May 7, 2014 after the close of the U.S. financial markets....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 30, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/new-experimental-vaccine-produces-immune-response-against-middle" hreflang="en">New Experimental Vaccine Produces Immune Response Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>University of Maryland School of Medicine Study Published in Vaccine Highlights First Potential Effective Means for Preventing MERS Coronavirus Outbreak BALTIMORE and GAITHERSBURG, Md. , April 30, 2014 (GLOBE NEWSWIRE) -- The University of Maryland School of Medicine ( UM SOM ) and Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 28, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-top-line-data-dose-confirmatory-phase" hreflang="en">Novavax Announces Positive Top-Line Data from Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate in Women of Childbearing Age</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Vaccine candidate was well-tolerated with no vaccine-related serious adverse events Highest immune responses observed with a single dose of vaccine combined with aluminum phosphate adjuvant Women with the lowest baseline levels of RSV neutralizing antibodies had the largest increases following immun...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 07, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-dr-cindy-oliver-senior-vice-president-process" hreflang="en">Novavax Appoints Dr. Cindy Oliver as Senior Vice President, Process Development Operations</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 7, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced the appointment of Cynthia N. Oliver , Ph.D....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 02, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-13th-annual-needham-healthcare-conference" hreflang="en">Novavax to Present at the 13th Annual Needham Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , April 2, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 10, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-year-end-2013-financial" hreflang="en">Novavax Reports Fourth-Quarter and Year-End 2013 Financial Results and Initiation of Phase 1/2 Clinical Trial of Its H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , March 10, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 10, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-john-j-trizzino-senior-vice-president" hreflang="en">Novavax Appoints John J. Trizzino as Senior Vice President, Commercial Operations</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , March 10, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced the appointment of John J....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 27, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-extension-contract-advanced-development" hreflang="en">Novavax Announces Extension of Contract for Advanced Development of Recombinant Influenza Products and Pandemic Preparedness With HHS-BARDA</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>GAITHERSBURG, Md. , Feb. 27, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the execution of a contract modification to extend the base period of performance of its current contract with the U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 19, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-fourth-quarter-and-year-end-2013-financial" hreflang="en">Novavax to Report Fourth Quarter and Year-End 2013 Financial Results on March 10, 2014</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Feb. 19, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it will host a conference call and webcast to report its fourth quarter and year-end 2013 financial results on Monday, March 10, 2014 , at 4:30 p.m. ET ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 13, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-continuation-rsv-vaccine-partnership-path" hreflang="en">Novavax Announces Continuation of RSV Vaccine Partnership With PATH</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Jan. 13, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced the continuation of their partnership with PATH to develop Novavax &#039; RSV (respiratory syncytial virus) vaccine for maternal immunization....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 13, 2014 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-management-promotions-support-expanded" hreflang="en">Novavax Announces Management Promotions to Support Expanded Clinical Activity in 2014</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Jan. 13, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced a number of promotions within its clinical operations group in preparation for expanded clinical trial activities in 2014 and 2015. Gregory M. Glenn , M.D....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 26, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-25th-annual-piper-jaffray-healthcare-conference" hreflang="en">Novavax to Present at the 25th Annual Piper Jaffray Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Nov. 26, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 13, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/new-england-journal-medicine-publishes-positive-data-clinical" hreflang="en">New England Journal of Medicine Publishes Positive Data From Clinical Trial of Novavax&#039; Vaccine Against H7N9 Avian Flu</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Nov 13, 2013 (GLOBE NEWSWIRE via COMTEX) -- Data are industry&#039;s first from clinical trial of vaccine against A(H7N9) strain of influenza 81% of 5ug adjuvanted vaccine recipients had protective HAI levels 97% of 5ug adjuvanted vaccine recipients had anti-neuraminidase antibody respons...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 07, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2013-financial-results" hreflang="en">Novavax Reports Third-Quarter 2013 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Nov. 7, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 30, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-third-quarter-2013-financial-results-november-7" hreflang="en">Novavax to Report Third Quarter 2013 Financial Results on November 7, 2013</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Oct. 30, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it will host a conference call and live webcast to report its third quarter 2013 financial results on Thursday, November 7, 2013 , at 4:30 p.m. ET ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 07, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-dose-confirmatory-phase-2-clinical-trial-its" hreflang="en">Novavax Initiates Dose-Confirmatory Phase 2 Clinical Trial of its RSV Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Oct. 7, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that enrollment has begun in a Phase 2 dose-confirmatory clinical trial of its respiratory syncytial virus (RSV) vaccine candidate in women of childbearing age....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 27, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-completes-100-million-public-offering-common-stock" hreflang="en">Novavax Completes $100 Million Public Offering of Common Stock</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Sept. 27, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 24, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-prices-public-offering-common-stock" hreflang="en">Novavax Prices Public Offering of Common Stock</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Sept. 24, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 24, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiate-seasonal-and-pandemic-influenza-trials" hreflang="en">Novavax to Initiate Seasonal and Pandemic Influenza Trials in Collaboration With BARDA</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Quadrivalent Seasonal Influenza Clinical Trial to start in 1Q2014 Pandemic Influenza Clinical Trial to start in the U.S. in 1H2014 Proprietary Adjuvant Matrix-M to be used in the Pandemic Clinical Trial ROCKVILLE, Md. , Sept. 24, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 17, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-host-analyst-and-investor-update-call-webcast" hreflang="en">Novavax to Host an Analyst and Investor Update Call With Webcast</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Sept. 17, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 13, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-highlights-positive-results-partners-clinical-trial" hreflang="en">Novavax Highlights Positive Results From Partner&#039;s Clinical Trial of Vaccine Using Matrix-M(TM)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Genocea Biosciences&#039; Herpes Simplex Therapeutic Vaccine uses Matrix-M adjuvant Phase 1/2A U.S.-based clinical trial enrolled 143 volunteers with moderate-to-severe HSV-2 Two highest dose Matrix-M adjuvanted cohorts demonstrated statistically significant reductions in viral shedding Genocea&#039;s Phase 2...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 11, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/icaac-presentations-highlight-potential-protective-effects" hreflang="en">ICAAC Presentations Highlight Potential Protective Effects of Novavax&#039; RSV Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Sept. 11, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 05, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-2013-stifel-nicolaus-healthcare-conference" hreflang="en">Novavax to Present at the 2013 Stifel Nicolaus Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Sept. 5, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc . (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck , President and Chief Executive Officer, will present at the 2013 Stifel Nicolaus Healthcare Conference on Thursday, September 12, 2013 at 9:45 a.m....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 03, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-rsv-vaccine-clinical-and-preclinical-results" hreflang="en">Novavax to Present RSV Vaccine Clinical and Preclinical Results at ICAAC</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Sept. 3, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 08, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-second-quarter-2013-financial-results" hreflang="en">Novavax Reports Second-Quarter 2013 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Aug. 8, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 06, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-2013-wedbush-life-sciences-conference" hreflang="en">NOVAVAX to Present at the 2013 Wedbush Life Sciences Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Aug. 6, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 01, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-second-quarter-2013-financial-results-august-8" hreflang="en">Novavax to Report Second Quarter 2013 Financial Results on August 8, 2013</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Aug. 1, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it will host a conference call and live webcast to report its second quarter 2013 financial results on Thursdsay, August 8, 2013 , at 8:30 a.m. ET ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 29, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-publishes-positive-preclinical-efficacy-data-against" hreflang="en">Novavax Publishes Positive Preclinical Efficacy Data Against Influenza A(H7N9)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Positive efficacy data from its A(H7N9) vaccine published in the peer-reviewed scientific journal Vaccine Novavax vaccine-induced immunity provided 100% protection against lethal wild-type A(H7N9) influenza challenge versus 0% survival in control (H5N1) vaccine and placebo groups Achieved complete c...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 08, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-first-phase-1-clinical-trial-its-ah7n9" hreflang="en">Novavax Initiates First Phase 1 Clinical Trial of Its A(H7N9) Influenza Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , July 8, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 02, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-top-line-results-phase-1-clinical" hreflang="en">Novavax Announces Positive Top-Line Results From Phase 1 Clinical Trial of RSV Vaccine Candidate in Elderly</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Well-tolerated without any vaccine-related serious adverse events Adjuvant enhanced response seen in all dose levels Anti-F IgG antibodies to the F protein in serum rose 3.0-5.7 fold across all dose levels Palivizumab-like antibodies rose from undetectable levels to those previously associated with...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 24, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-barclay-buck-phillips-senior-vice-president-and" hreflang="en">Novavax Appoints Barclay &quot;Buck&quot; Phillips as Senior Vice President and Chief Financial Officer</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , June 24, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced the appointment of Barclay A. &quot;Buck&quot; Phillips to the position of Senior Vice President and Chief Financial Officer, effective June 24, 2013 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 06, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-produces-mers-cov-vaccine-candidate" hreflang="en">Novavax Produces MERS-CoV Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , June 6, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it had successfully produced a vaccine candidate designed to provide protection against the recently emerging Middle East Respiratory Syndrome Coronavirus (MERS-CoV)....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 04, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-public-offer-all-outstanding-shares-isconova" hreflang="en">Novavax Announces Public Offer for All Outstanding Shares of Isconova</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Adds proprietary nanoparticle matrix immune-modulating adjuvant technology to Novavax&#039;s recombinant vaccine development platform Total transaction valued at approximately $29.6 million USD Conference call with management to discuss acquisition at 10:00 a.m. EDT today ROCKVILLE, Md....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 10, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-h7n9-vlp-influenza-vaccine-enters-animal-testing" hreflang="en">Novavax H7N9 VLP Influenza Vaccine Enters Animal Testing</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Novavax H7N9 VLP vaccine produced, purified and entered into preclinical immunogenicity and efficacy studies in less than a month Production of GMP H7N9 clinical trial materials underway ROCKVILLE, Md. , May 10, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 07, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2013-financial-results" hreflang="en">Novavax Reports First-Quarter 2013 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Key Highlights Phase II RSV clinical trial data achieve protocol specified-objectives of safety and immunogenicity....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 26, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-first-quarter-2013-financial-results-may-7-2013" hreflang="en">Novavax to Report First-Quarter 2013 Financial Results on May 7, 2013</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , April 26, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it will report its 2013 first-quarter financial results on Tuesday, May 7, 2013 , before the U.S. financial markets open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 25, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-12th-annual-needham-healthcare-conference" hreflang="en">Novavax to Present at 12th Annual Needham Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , April 25, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 15, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-review-recent-findings-vaccine-programs-world-vaccine" hreflang="en">Novavax to Review Recent Findings from Vaccine Programs at World Vaccine Congress and Expo in Washington, DC</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , April 15, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it will review recent clinical results from the company&#039;s vaccine development programs at the World Vaccine Congress and Expo this week in Washington, DC ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 10, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-amy-b-fix-vice-president-regulatory-affairs" hreflang="en">Novavax Appoints Amy B. Fix Vice President of Regulatory Affairs</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , April 10, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced the appointment of Amy B. Fix to the position of Vice President of Regulatory Affairs....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 02, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-positive-top-line-results-phase-ii-clinical" hreflang="en">Novavax Reports Positive Top-Line Results From Phase II Clinical Trial of RSV Vaccine Candidate in Women of Childbearing Age</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Well-tolerated and without any vaccine related serious adverse events (SAEs) Anti-F IgG antibodies to the F protein in serum rose 6 to 16-fold across all doses (60 and 90 µg)....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 18, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-progress-rsv-vaccine-xv-international-symposium" hreflang="en">Novavax Reports Progress on RSV Vaccine at the XV International Symposium on Respiratory Viral Infections</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , March 18, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) reported that David C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 13, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-25th-annual-roth-conference" hreflang="en">Novavax to Present at the 25th Annual ROTH Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , March 13, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 08, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-cplb-and-icgeb-collaboration-honored-malaria-vaccine" hreflang="en">Novavax, CPLB and ICGEB Collaboration Honored for Malaria Vaccine Progress at Vaccine World Summit India 2013</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , March 8, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 01, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-year-end-2012-financial" hreflang="en">Novavax Reports Fourth Quarter and Year-End 2012 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , March 1, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the fourth quarter and year-ended December 31, 2012 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 22, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-2012-fourth-quarter-and-year-end-financial" hreflang="en">Novavax to Report 2012 Fourth-Quarter and Year-End Financial Results on March 1, 2013</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Feb. 22, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 fourth-quarter and year-end financial results on Friday, March 1, 2013 , before the U.S. financial markets open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 07, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-15th-annual-bio-ceo-investor-conference" hreflang="en">NOVAVAX to Present at the 15th Annual Bio CEO &amp; Investor Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Feb. 7, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Frederick W....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 24, 2013 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/barda-continues-novavax-influenza-vaccine-programs-following" hreflang="en">BARDA Continues Novavax&#039; Influenza Vaccine Programs Following In-Process Review</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Jan. 24, 2013 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that the U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 06, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-phase-i-rsv-vaccine-data-published-vaccine" hreflang="en">Novavax&#039; Phase I RSV Vaccine Data Published in Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Vaccine was well-tolerated with no evident dose-related toxicity or attributable SAEs Immunization induced significant increases in neutralizing antibody responses ROCKVILLE, Md. , Dec. 6, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 03, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-publishes-preclinical-efficacy-study-its-rsv-protein" hreflang="en">Novavax Publishes Preclinical Efficacy Study of its RSV Protein Nanoparticle Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Dec. 3, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 20, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-24th-annual-piper-jaffray-healthcare-conference" hreflang="en">Novavax to Present at the 24th Annual Piper Jaffray Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Nov. 20, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 12, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-lazard-capital-markets-9th-annual-healthcare" hreflang="en">Novavax to Present at the Lazard Capital Markets 9th Annual Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Nov. 12, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 02, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2012-financial-results" hreflang="en">Novavax Reports Third-Quarter 2012 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Nov. 2, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the third quarter and nine months ended September 30, 2012 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 26, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-third-quarter-2012-financial-results-november-2" hreflang="en">Novavax to Report Third Quarter 2012 Financial Results on November 2, 2012</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Oct. 26, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 third-quarter financial results on Friday, November 2, 2012 , before the U.S. financial markets open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 23, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-27-million-equity-offering" hreflang="en">Novavax Announces $27 Million Equity Offering</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Oct. 23, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 17, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-positive-top-line-results-two-phase-1-trials" hreflang="en">Novavax Reports Positive Top-Line Results From Two Phase 1 Trials of Pandemic Influenza Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Vaccine candidates met safety and immunogenicity endpoints in both trials Trials&#039; results support further development of vaccine in larger trials -- Adjuvanted candidates, at all doses of antigen tested including 3.75 µg dose, achieved dose-sparing goals with seroconversion and seroprotection rates...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 15, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-1-clinical-trial-rsv-vaccine-candidate" hreflang="en">Novavax Initiates Phase 1 Clinical Trial of RSV Vaccine Candidate in Elderly Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Oct. 15, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that enrollment has begun in a Phase 1 dose-ranging clinical trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adults 60 years of age and older....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 08, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-phase-2-clinical-trial-rsv-vaccine-candidate" hreflang="en">Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Oct. 8, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that enrollment has begun in a Phase 2 dose-ranging clinical trial of its respiratory syncytial virus (RSV) vaccine candidate in women of childbearing age....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 27, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-presents-rsv-vaccine-data-8th-annual-international" hreflang="en">Novavax Presents RSV Vaccine Data at the 8th Annual International Respiratory Virus Symposium</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Data Reinforce Previous Clinical and Preclinical Studies Successfully Induced F-Protein Specific Neutralizing Antibody Response Phase 2 Studies to Begin in the Fourth Quarter of 2012 ROCKVILLE, Md. , Sept. 27, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 06, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-rodman-renshaw-14th-annual-healthcare-conference" hreflang="en">NOVAVAX to Present at the Rodman &amp; Renshaw 14th Annual Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Sept. 6, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 04, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-2012-stifel-nicolaus-healthcare-conference" hreflang="en">NOVAVAX to Present at the 2012 Stifel Nicolaus Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Sept. 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 13, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-2012-wedbush-life-sciences-conference" hreflang="en">NOVAVAX to Present at the 2012 Wedbush Life Sciences Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Aug. 13, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 03, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-second-quarter-2012-financial-results" hreflang="en">NOVAVAX Reports Second Quarter 2012 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Aug. 3, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2012 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 27, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-second-quarter-2012-financial-results-august-3" hreflang="en">NOVAVAX to Report Second Quarter 2012 Financial Results on August 3, 2012</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , July 27, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 second-quarter financial results on Friday, August 3, 2012 , before the U.S. financial markets open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 24, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-provides-update-influenza-programs" hreflang="en">NOVAVAX Provides Update on Influenza Programs</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Primary Endpoints Achieved in Phase II Seasonal Influenza Trial Two H5N1 Pandemic Influenza Trials Fully Enrolled ROCKVILLE, Md. , July 24, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 18, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-path-announce-partnership-rsv-vaccine" hreflang="en">NOVAVAX and PATH Announce Partnership on RSV Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Novavax initially awarded approximately $2 million by PATH Potential for future PATH funding of 50% of external costs to develop maternal RSV vaccine available for low-resource countries Novavax retains global rights to commercialize RSV vaccine ROCKVILLE, Md....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 16, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-cpl-biologicals-and-international-centre-genetic" hreflang="en">NOVAVAX, CPL Biologicals and the International Centre for Genetic Engineering and Biotechnology Announce Collaboration to Develop New Malaria Vaccine With Funding From Government of India</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , July 16, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), CPL Biologicals (CPLB) and the International Centre for Genetic Engineering and Biotechnology (ICGEB), today announced that they have formed a new collaboration to develop a novel malaria vaccine in India ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 05, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-progress-rsv-vaccine-new-international" hreflang="en">NOVAVAX Reports on Progress with RSV Vaccine at New International Conference on Modern Vaccines</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , July 5, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 27, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-review-rsv-program-new-international-conference-modern" hreflang="en">Novavax to Review RSV Program at New International Conference on Modern Vaccines</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , June 27, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 04, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-jefferies-2012-global-healthcare-conference" hreflang="en">NOVAVAX to Present at Jefferies 2012 Global Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , June 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 21, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-12-million-equity-offering" hreflang="en">NOVAVAX, Inc. Announces $12 Million Equity Offering</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , May 21, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that on Friday, May 18, 2012 , it sold 10,000,000 shares of its common stock to RA Capital Healthcare Fund, LP at a price of $1.22 per share....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 09, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-launches-additional-phase-i-clinical-trial-ah5n1" hreflang="en">NOVAVAX Launches Additional Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , May 9, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 04, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2012-financial-results" hreflang="en">NOVAVAX Reports First Quarter 2012 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , May 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the first quarter ended March 31, 2012 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 02, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-launches-phase-i-clinical-trial-ah5n1-influenza-vaccine" hreflang="en">NOVAVAX Launches Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , May 2, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 26, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-first-quarter-2012-financial-results-may-4-2012" hreflang="en">NOVAVAX to Report First Quarter 2012 Financial Results on May 4, 2012</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , April 26, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 first-quarter financial results on Friday, May 4, 2012 , before the U.S. financial markets open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 03, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-11th-annual-needham-healthcare-conference" hreflang="en">NOVAVAX to Present at the 11th Annual Needham Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , April 3, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Frederick W....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 22, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-results-phase-i-rsv-study-xiv-international" hreflang="en">NOVAVAX to Present Results From Phase I RSV Study at XIV International Symposium on Respiratory Viral Infections</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , March 22, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that Louis F....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 12, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-24th-annual-roth-conference" hreflang="en">NOVAVAX to Present at the 24th Annual ROTH Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , March 12, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 09, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-2011-year-end-financial" hreflang="en">NOVAVAX Reports Fourth Quarter and 2011 Year-End Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , March 9, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the fourth quarter and year ended December 31, 2011 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 08, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-john-herrmann-iii-vice-president-and-general" hreflang="en">NOVAVAX Appoints John A. Herrmann III, Vice President and General Counsel</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , March 8, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Mr. John A. Herrmann III to the position of Vice President and General Counsel. Mr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 01, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-launches-phase-ii-clinical-trial-seasonal-influenza" hreflang="en">NOVAVAX Launches Phase II Clinical Trial of Seasonal Influenza Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , March 1, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has begun enrollment in a Phase II clinical trial of its quadrivalent seasonal influenza virus-like particle (VLP) vaccine candidate....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 24, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-2011-fourth-quarter-and-year-end-financial" hreflang="en">NOVAVAX to Report 2011 Fourth-Quarter and Year-End Financial Results on March 9, 2012</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Feb. 24, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2011 fourth-quarter and year-end financial results on Friday, March 9, 2012 , before the U.S. financial markets open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 10, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-14th-annual-bio-ceo-investor-conference" hreflang="en">NOVAVAX to Present at the 14th Annual Bio CEO &amp; Investor Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Feb. 10, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Frederick W....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 01, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-mervyn-l-hamer-vice-president-manufacturing" hreflang="en">NOVAVAX Appoints Mervyn L. Hamer, Vice President of Manufacturing</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Feb. 1, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Mr. Mervyn L. Hamer to the position of Vice President of Manufacturing. In this role, Mr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 03, 2012 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-progress-under-joint-venture-india-cadila" hreflang="en">NOVAVAX Reports Progress Under Joint Venture in India With Cadila Pharmaceuticals</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Regulatory approval received for rabies vaccine toxicology studies in India Clinical study of influenza vaccine candidate planned for 2012 Validated manufacturing facility ready for clinical production Additional new vaccines in development for undisclosed targets ROCKVILLE, Md. , Jan....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 28, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-23rd-annual-piper-jaffray-health-care-conference" hreflang="en">NOVAVAX to Present at 23rd Annual Piper Jaffray Health Care Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Nov 28, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 21, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-acquires-new-manufacturing-and-office-facilities" hreflang="en">NOVAVAX Acquires New Manufacturing and Office Facilities in Gaithersburg, MD</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md. , Nov. 21, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has entered a long-term lease arrangement for 74,000-square-feet of manufacturing, lab and office space in two facilities in Gaithersburg, MD ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 10, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-lazard-capital-markets-8th-annual-healthcare" hreflang="en">NOVAVAX to Present at the Lazard Capital Markets 8th Annual Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Nov 10, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Frederick W....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 07, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-russell-rip-wilson-senior-vice-president" hreflang="en">NOVAVAX Appoints Russell &quot;Rip&quot; Wilson Senior Vice President of Business Development</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Nov 7, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Russell P. &quot;Rip&quot; Wilson as Senior Vice President of Business Development. Mr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 04, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2011-financial-results" hreflang="en">NOVAVAX Reports Third Quarter 2011 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Nov 4, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the third quarter ended September 30, 2011....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 03, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-erica-s-shane-phd-vice-president-process" hreflang="en">NOVAVAX Appoints Erica S. Shane, Ph.D., Vice President, Process Development</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Nov 3, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Erica Shane, Ph.D., to the position of Vice President, Process Development. In this role, Dr. Shane will have responsibility for all process development activities for Novavax....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 28, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-third-quarter-2011-financial-results-november-4" hreflang="en">NOVAVAX to Report Third Quarter 2011 Financial Results on November 4, 2011</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Oct 28, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) will report financial results for the third fiscal quarter of 2011 on Friday, November 4, 2011, before the U.S. financial markets open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 27, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-addresses-us-patent-and-trademark-office-uspto" hreflang="en">NOVAVAX CEO Addresses U.S. Patent and Trademark Office (USPTO) on Behalf of the Biotechnology Industry Organization (BIO)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Oct 27, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) today announced that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 10, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-conference-call-discuss-results-phase-i-trial" hreflang="en">NOVAVAX Announces Conference Call to Discuss Results From Phase I Trial of Respiratory Syncytial Virus Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Oct 10, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 05, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-contract-award-us-department-homeland-security" hreflang="en">NOVAVAX Announces Contract Award from U.S. Department of Homeland Security to Develop Foot-and-Mouth Disease Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Oct 5, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has been awarded a $1.3 million contract from the U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 03, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-positive-results-phase-i-trial-respiratory" hreflang="en">NOVAVAX Reports Positive Results From Phase I Trial of Respiratory Syncytial Virus Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Oct 3, 2011 (GlobeNewswire via COMTEX) -- - Well-tolerated with no systemic side-effect trends - Highly immunogenic with an increase in anti-RSV antibodies in 100% of subjects in the highest-dose group - Oral and poster presentations to be made at 5th Vaccine and ISV Annual Global Conference in Seat...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 26, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-top-line-results-phase-i-respiratory-syncytial" hreflang="en">Novavax to Report Top-Line Results From Phase I Respiratory Syncytial Virus Vaccine Clinical Trial on October 3rd at 5th Vaccine and ISV Annual Global Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Sep 26, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 08, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-publication-results-h5n1-influenza-virus" hreflang="en">NOVAVAX Announces Publication of Results From H5N1 Influenza Virus-Like Particle Vaccine Phase I/IIa Clinical Trial</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Sep 8, 2011 (GlobeNewswire via COMTEX) -- VLP vaccine candidate was well-tolerated, immunogenic and generated cross-reactive neutralizing antibodies ROCKVILLE, Md., Sept. 8, 2011 (GLOBE NEWSWIRE) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 06, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-stifel-nicolaus-healthcare-conference" hreflang="en">NOVAVAX to Present at Stifel Nicolaus Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Sep 6, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 16, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-2011-wedbush-life-sciences-conference" hreflang="en">Novavax to Present at the 2011 Wedbush Life Sciences Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Aug 16, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 05, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-second-quarter-2011-financial-results" hreflang="en">Novavax Reports Second Quarter 2011 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Aug 5, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the second quarter ended June 30, 2011....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 04, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-mexican-social-security-institute-publish-results" hreflang="en">NOVAVAX and the Mexican Social Security Institute Publish Results From H1N1 Influenza Vaccine Trial in Mexico</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Aug 4, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 29, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-second-quarter-2011-financial-results-august-5" hreflang="en">Novavax to Report Second Quarter 2011 Financial Results on August 5, 2011</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Jul 29, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) will report financial results for the second quarter of 2011 on Friday, August 5, 2011, before the U.S. financial markets open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 28, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-dr-timothy-hahn-senior-vice-president" hreflang="en">Novavax Appoints Dr. Timothy Hahn Senior Vice President of Manufacturing</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Jun 28, 2011 (GlobeNewswire via COMTEX) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Timothy J. Hahn, Ph.D., as Senior Vice President of Manufacturing. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 13, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-noble-financial-7th-annual-equity-conference" hreflang="en">NOVAVAX to Present at the NOBLE FINANCIAL 7th Annual Equity Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 13, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 11, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-named-biotechnology-firm-year-tech-council-maryland" hreflang="en">Novavax Named Biotechnology Firm of the Year by Tech Council of Maryland</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 11, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) has been named Biotechnology Firm of the Year by the Tech Council of Maryland (TCM), the largest technology trade group serving the advanced technology and biotechnology communities of Maryland ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 09, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2011-financial-results" hreflang="en">Novavax Reports First Quarter 2011 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 9, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results for the first quarter ended March 31, 2011 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 03, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-first-quarter-2011-financial-results-may-9-2011" hreflang="en">Novavax to Report First Quarter 2011 Financial Results on May 9, 2011</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 3, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) will report financial results for the first quarter of 2011 on Monday, May 9, 2011 , before the U.S. financial markets open. The announcement will be followed by a webcast and conference call hosted by Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 26, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-senior-management-appointments" hreflang="en">Novavax Announces Senior Management Appointments</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., April 26, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the appointments of Louis Fries III , M.D., as Vice President, Clinical and Medical Affairs, and Jane Halpern , Ph.D., as Vice President of Regulatory Affairs. Before joining Novavax, Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 19, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-change-leadership" hreflang="en">Novavax Announces Change in Leadership</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- Stanley Erck appointed President &amp;amp; CEO - James Young, Ph.D. becomes Chairman of the Board ROCKVILLE, Md., April 19, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 05, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavaxs-vlp-influenza-vaccine-named-one-top-100-drugs" hreflang="en">Novavax&#039;s VLP Influenza Vaccine Named One of Top 100 Drugs in Development Today</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., April 5, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (NASDAQ: NVAX) announced that its virus-like particle (VLP) influenza vaccine has been named by the editors of R&amp;amp;D Directions magazine as one of the top &quot;100 great investigational drugs in development&quot; today....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 28, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-2010-year-end-financial" hreflang="en">NOVAVAX Reports Fourth Quarter and 2010 Year-End Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 28, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the fourth quarter and year ended December 31, 2010 ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 23, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-2010-year-end-financial-results" hreflang="en">NOVAVAX Announces Release Date of 2010 Year-End Financial Results and Investor Conference Call</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 23, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2010 year-end financial results in a press release to be issued after 8:00 a.m....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 22, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-bit-life-sciences-3rd-world-congress-vaccine" hreflang="en">NOVAVAX to Present at BIT Life Science&#039;s 3rd World Congress of Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 22, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 11, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-roth-23rd-annual-oc-growth-stock-conference" hreflang="en">NOVAVAX to Present at the ROTH 23rd Annual OC Growth Stock Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 11, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 03, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/maryland-governor-martin-omalley-visit-novavax-celebration-hhs" hreflang="en">Maryland Governor Martin O&#039;Malley to Visit Novavax in Celebration of HHS-BARDA Contract Award</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>-- BARDA contract valued at up to $179 Million to Develop Pandemic and Seasonal Influenza Vaccines for U.S. Government Using Recombinant VLP Technology -- Includes $97 Million 3-year Base Period and $82 Million 2-year Option Period Press Conference at 9:15 a.m....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 01, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-awarded-hhs-barda-contract-valued-179-million-develop" hreflang="en">NOVAVAX Awarded HHS-BARDA Contract Valued at up to $179 Million to Develop Pandemic and Seasonal Influenza Vaccines for U.S. Government Using Recombinant VLP Technology</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>-- Contract Includes $97 Million 3-year Base Period and $82 Million 2-year Option Period -- Base Period Will Fund Seasonal Influenza Vaccine through Phase 3 and Potential FDA Licensure; Pandemic Influenza Vaccine Candidates through Phase 1/2 Clinical Trials -- Includes Development of Manufacturing P...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 28, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-licenses-recombinant-vlp-influenza-vaccine-lg-life" hreflang="en">Novavax Licenses Recombinant VLP Influenza Vaccine to LG Life Sciences for South Korea and Other Countries</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- 15 million dose South Korean market - LG to build manufacturing facility with 30 million dose influenza vaccine capacity ROCKVILLE, Md., March 1, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 24, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-citi-2011-global-health-care-conference" hreflang="en">NOVAVAX to Present at Citi 2011 Global Health Care Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Feb. 24, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 18, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-presents-final-results-h1n1-influenza-vaccine-trial" hreflang="en">NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Feb. 18, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 10, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-13th-annual-bio-ceo-investor-conference" hreflang="en">NOVAVAX to Present at 13th Annual BIO CEO &amp; Investor Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Feb. 10, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 09, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-h1n1-vlp-influenza-vaccine-clinical-data-7th" hreflang="en">NOVAVAX to Present H1N1 VLP Influenza Vaccine Clinical Data at 7th World Health Organization (WHO) Meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Feb. 9, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 04, 2011 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-launches-phase-i-clinical-trial-evaluate-its-novel" hreflang="en">NOVAVAX Launches Phase I Clinical Trial to Evaluate its Novel Vaccine Against Respiratory Syncytial Virus (RSV)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Vaccine candidate targets world&#039;s leading cause of infant death and childhood respiratory disease ROCKVILLE, Md., Jan. 4, 2011 /PRNewswire via COMTEX/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 22, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-university-massachusetts-medical-school-publish" hreflang="en">NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Vaccine candidate completely protects mice from RSV replication in the lungs ROCKVILLE, Md., Dec. 22, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) and scientists at the University of Massachusetts Medical School , led by Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 16, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-receives-fda-clearance-launch-phase-i-rsv-vaccine" hreflang="en">NOVAVAX Receives FDA Clearance to Launch Phase I RSV Vaccine Clinical Trial</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Dec. 16, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that the company&#039;s Phase I clinical trial to evaluate a new vaccine candidate to prevent respiratory syncytial virus (RSV) infection has been cleared by the U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 29, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-piper-jaffray-22nd-annual-healthcare-conference" hreflang="en">NOVAVAX to Present at Piper Jaffray 22nd Annual Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Nov. 29, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage biopharmaceutical company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax, will be presenting at the Piper Jaffray 22nd Annual Healthcare Conference....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 11, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-lazard-7th-annual-healthcare-conference" hreflang="en">NOVAVAX to Present at Lazard 7th Annual Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Nov. 11, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage biopharmaceutical company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax will be presenting at the Lazard 7th Annual Healthcare Conference....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 05, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2010-financial-results" hreflang="en">NOVAVAX Reports Third Quarter 2010 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Nov. 5, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the third quarter ended September 30, 2010....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 04, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-awarded-nearly-1-million-grants-irs-under-qualifying" hreflang="en">NOVAVAX Awarded Nearly $1 Million in Grants from IRS Under Qualifying Therapeutic Discovery Project</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Nov. 4, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that it has been awarded approximately $978,000 in grants under the Internal Revenue Service&#039;s Qualifying Therapeutic Discovery Project (&quot;QTDP&quot;)....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 15, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-third-quarter-2010-financial-results-november-5" hreflang="en">Novavax to Report Third Quarter 2010 Financial Results on November 5, 2010</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Oct 15, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 29, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-bio-investor-forum" hreflang="en">NOVAVAX to Present at BIO Investor Forum</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Sept 29, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage biopharmaceutical company, announced today that Mr. Frederick Driscoll, Chief Financial Officer of Novavax, will be presenting at the BIO Investor Forum....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 08, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-stifel-nicolaus-conference" hreflang="en">NOVAVAX to Present at Stifel Nicolaus Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Sept 08, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Mr. Frederick Driscoll, Chief Financial Officer of Novavax will be presenting at the Stifel Nicolaus Conference....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 08, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-interscience-conference-antimicrobial-agents-and" hreflang="en">NOVAVAX to Present at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Sept 08, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that the company will be presenting at the American Society for Microbiology (ASM) sponsored, ICAAC....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 19, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-endorses-new-us-initiatives-develop-medical" hreflang="en">NOVAVAX Endorses New U.S. Initiatives to Develop Medical Countermeasures</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Aug 19, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) President and CEO Dr. Rahul Singhvi today attended the press briefing by U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 17, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-immunotherapeutics-and-vaccine-imvac-summit" hreflang="en">NOVAVAX to Present at the Immunotherapeutics and Vaccine (IMVAC) Summit</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Aug 17, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that the company will be presenting at the IMVAC Summit. The Conference will take place August 17-19, 2010 at the Royal Sonesta Hotel, Cambridge, MA. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 12, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-positive-results-pre-clinical-safety-study" hreflang="en">Novavax Reports Positive Results from Pre-Clinical Safety Study of Respiratory Syncytial Virus (RSV) Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Aug 12, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) reported today that results from a pre-clinical toxicology study of its vaccine candidate to prevent respiratory syncytial virus (RSV), showed the vaccine to be safe and well-tolerated at all doses tested....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 06, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-second-quarter-2010-financial-results" hreflang="en">NOVAVAX Reports Second Quarter 2010 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Aug 06, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the second quarter ended June 30, 2010....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 06, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-elects-richard-h-douglas-its-board-directors" hreflang="en">NOVAVAX Elects Richard H. Douglas to its Board of Directors</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Aug 06, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the appointment of Richard Douglas, Ph.D. to its board of directors. Dr. Douglas is currently Senior Vice President, Corporate Development at Genzyme Corp....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 30, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-second-quarter-2010-financial-results-august-6" hreflang="en">Novavax to Report Second Quarter 2010 Financial Results on August 6, 2010</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., July 30, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 27, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-issuance-key-us-patent-influenza-virus" hreflang="en">NOVAVAX Announces Issuance of Key U.S. Patent for Influenza Virus-Like Particle (VLP) Vaccines</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Patent claims cover technology for rapid, efficient, and uniform production of VLP vaccines from strains of seasonal and pandemic influenza. ROCKVILLE, Md., July 27, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the issuance of U.S. Patent No....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 06, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-appointment-dr-gregory-glenn-chief-scientific" hreflang="en">Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., July 6, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) announced today the appointment of Gregory Glenn, M.D., as the company&#039;s Chief Scientific Officer who will report to Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax. Previously, Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 18, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-present-phacilitate-vaccine-forum-barcelona-2010" hreflang="en">Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., June 18, 2010 /PRNewswire via COMTEX/ --Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 14, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-manufacturing-management-appointments" hreflang="en">Novavax Announces Manufacturing Management Appointments</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Promotions reflect substantial progress in improving manufacturing process ROCKVILLE, Md., June 14, 2010 /PRNewswire via COMTEX/ --Novavax, Inc. (Nasdaq: NVAX) announced today the appointments of John W....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 10, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-completion-construction-vaccine-production" hreflang="en">Novavax Announces Completion of Construction of Vaccine Production Facility in India</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- CPL Biologicals state-of-the-art vaccine facility operational in Dholka, India - Validation testing to begin this month - Annual bulk production capacity projected at 60 million doses of VLP influenza vaccine - Sterile filling capacity available ROCKVILLE, Md., June 10, 2010 /PRNewswire via COMTEX...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 24, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-appointment-dr-mark-thornton-senior-vice" hreflang="en">Novavax Announces Appointment of Dr. Mark Thornton as Senior Vice President, Development and Chief Medical Officer</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 24, 2010 /PRNewswire via COMTEX/ --Novavax, Inc. (Nasdaq: NVAX) announced today the appointment of Mark O. Thornton, M.D., M.P.H., Ph.D., as the company&#039;s Senior Vice President, Development and Chief Medical Officer. Before joining Novavax, Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 13, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-publication-pre-clinical-study-its-pandemic" hreflang="en">Novavax Announces Publication of a Pre-clinical Study with its Pandemic 2009 H1N1 Influenza Virus-Like Particle (VLP) Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>First report of a vaccine protecting ferrets against the 2009 pandemic H1N1 virus is published in the journal Vaccine ROCKVILLE, Md., May 13, 2010 /PRNewswire via COMTEX/ --Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 10, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2010-financial-results" hreflang="en">NOVAVAX Reports First Quarter 2010 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 10, 2010 /PRNewswire via COMTEX/ --Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the first quarter ended March 31, 2010....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 04, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-first-quarter-2010-financial-results-may-10-2010" hreflang="en">Novavax to Report First Quarter 2010 Financial Results on May 10, 2010</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 4, 2010 /PRNewswire via COMTEX/ --Novavax, Inc. (Nasdaq: NVAX) announced today that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 29, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavaxs-seasonal-influenza-vlp-vaccine-candidate-shows-positive" hreflang="en">Novavax&#039;s Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>-- Both 15 and 60 mcg doses well-tolerated and immunogenic in older adults 60 years or higher in age -- Preliminary evidence shows improved immunogenicity at higher VLP dose ROCKVILLE, Md., April 29, 2010 /PRNewswire via COMTEX/ --Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 22, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-notified-department-health-and-human-services-its" hreflang="en">NOVAVAX Notified by Department of Health and Human Services that its Proposal for a Contract Award is in the Competitive Range for the Advanced Development of its Recombinant Influenza Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., April 22, 2010 /PRNewswire via COMTEX/ --Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 07, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-elects-james-f-young-its-board-directors" hreflang="en">NOVAVAX Elects James F. Young to Its Board of Directors</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., April 7, 2010 /PRNewswire via COMTEX/ --Novavax, Inc. (Nasdaq: NVAX) announced today that it has appointed James F. Young, Ph.D., to its Board of Directors. Dr. Young will be an independent Board Member effective immediately. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 29, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-releases-final-results-its-trivalent-seasonal-influenza" hreflang="en">NOVAVAX Releases Final Results from its Trivalent Seasonal Influenza Vaccine Phase II Clinical Study in Healthy Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 29, 2010 /PRNewswire via COMTEX/ --Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, released the final results from a Phase II clinical trial evaluating Novavax&#039;s trivalent seasonal influenza Virus-like particle (VLP) vaccine candidate in healthy adults....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 24, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-clinical-results-first-stage-pivotal" hreflang="en">NOVAVAX Announces Positive Clinical Results from First Stage of Pivotal Study of 2009 A/H1N1 VLP Pandemic Influenza Vaccine in Mexico</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>-- Independent Data Safety Monitoring Board (DSMB) concludes that Novavax&#039;s 2009 H1N1 VLP pandemic influenza vaccine is well-tolerated and induces robust immune responses with a single injection at all dose levels tested -- Stage B enrollment completed with over 3,500 volunteers in the trial ROCKVIL...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 12, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-2009-year-end-financial" hreflang="en">NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 12, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq:NVAX)today announced financial results for the fourth quarter and year ended December 31, 2009....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 11, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-22nd-annual-roth-oc-growth-stock-conference" hreflang="en">NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 11, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax will be presenting at the 22nd Annual ROTH OC Growth Stock Conference....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 08, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-completes-enrollment-pivotal-h1n1-influenza-vaccine" hreflang="en">NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Enrollment in largest clinical study in Novavax&#039;s history of over 4,500 subjects completed in less than 5 months ROCKVILLE, Md., March 8, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 05, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-cowen-and-companys-30th-annual-health-care" hreflang="en">NOVAVAX to Present at Cowen and Company&#039;s 30th Annual Health Care Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 5, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax will be presenting at Cowen and Company&#039;s 30th Annual Health Care Conference....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 04, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-2009-year-end-financial-results" hreflang="en">NOVAVAX Announces Release Date of 2009 Year-End Financial Results and Investor Conference Call</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 4, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2009 year-end financial results in a press release to be issued after 8:00 a.m. local time on Friday, March 12, 2010....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 19, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-presents-positive-clinical-results-world-health" hreflang="en">NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- Positive Clinical Results from Pivotal Study of H1N1 Virus-Like Particle (VLP) Pandemic Influenza Vaccine in Mexico - Immunogenicity responses at all dose levels meet U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 18, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-receives-nasdaq-non-compliance-letter" hreflang="en">NOVAVAX, Inc. Receives NASDAQ Non-Compliance Letter</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Feb 18, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that it received a notice of deficiency, as expected, from the NASDAQ Stock Market (NASDAQ) listing qualifications department. As a result of the election of Stanley C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 18, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-named-fast-companys-top-ten-most-innovative-biotech" hreflang="en">NOVAVAX Named to Fast Company&#039;s Top Ten Most Innovative Biotech Companies List</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Feb 18, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Fast Company has placed Novavax as one of the Top Ten Most Innovative Companies in the Biotech industry....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 16, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/stanley-erck-elected-executive-chairman" hreflang="en">Stanley Erck Elected as Executive Chairman</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Feb 16, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) The Board of Directors of Novavax, Inc., announced today the election of Stanley Erck as Executive Chairman. The effective date of this leadership change is immediately. Previously, Mr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 08, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-additional-positive-data-its-trivalent-seasonal" hreflang="en">NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Data show significant Neuraminidase Inhibition Antibody Titers in VLP vaccine recipients ROCKVILLE, Md., Feb 08, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 08, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-terminates-negotiations-rovi-pharmaceuticals-influenza" hreflang="en">Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Feb 08, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 05, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-12th-annual-bio-ceo-investor-conference" hreflang="en">NOVAVAX to Present at the 12th Annual BIO CEO &amp; Investor Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Feb 08, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 25, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-phacilitate-vaccine-forum-washington-2010" hreflang="en">NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Jan 25, 2010 /PRNewswire via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that the company will be presenting at the upcoming Phacilitate Vaccine Forum Washington 2010....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 12, 2010 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-preclinical-results-its-respiratory" hreflang="en">NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- Recombinant F protein particle vaccine candidate protects cotton rats against live RSV - No evidence of enhanced disease in lungs of vaccinated animals challenged with RSV - Manufacturing process successfully scaled to produce cGMP material for toxicology study ROCKVILLE, Md., Jan 12, 2010 /PRNews...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 09, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-licenses-wyeths-virus-particle-technology" hreflang="en">Novavax Licenses Wyeth&#039;s Virus-Like Particle Technology</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., July 9 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 05, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-names-len-stigliano-chief-financial-officer" hreflang="en">Novavax Names Len Stigliano Chief Financial Officer</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., July 5 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) said today that Len Stigliano has been appointed Vice President, Chief Financial Officer and Treasurer, effective July 2, 2007. Mr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 21, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-executive-receives-cdc-science-award" hreflang="en">Novavax Executive Receives CDC Science Award</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., June 21 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that Rick A. Bright, Ph.D., vice president of global influenza programs, and co-authors received the Centers for Disease Control&#039;s Charles C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 18, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-restructuring-existing-convertible-debt" hreflang="en">Novavax Announces Restructuring of Existing Convertible Debt</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., June 18 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that it has reached agreement with 100% of the noteholders of its outstanding convertible notes to revise the conversion price and eliminate the redemption right(s) of the noteholders....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 14, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-present-piper-jaffray-london-health-care-conference" hreflang="en">Novavax CEO to Present at Piper Jaffray London Health Care Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., June 14 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) Chief Executive Officer Dr. Rahul Singhvi will present at the 2nd Annual Piper Jaffray London Health Care Conference at 4:40 p.m. local time at the Great Eastern Hotel in London on June 21, the company announced today....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 08, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-present-needhams-6th-annual-biotechnology-medical" hreflang="en">Novavax CEO to Present at Needham&#039;s 6th Annual Biotechnology &amp; Medical Technology Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., June 8 /PRNewswire-FirstCall/ -- Novavax Inc. Chief Executive Officer Dr. Rahul Singhvi will present at the 6th Annual Needham &amp;amp; Co. Biotechnology and Medical Technology Conference at 8 a.m. on Thursday, June 14 at the New York Palace Hotel in New York, the company announced today....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 01, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-pandemic-flu-vaccine-provided-protection-against-lethal" hreflang="en">Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal Challenge of Live Virus, Pre-Clinical Data Show</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Study Presented at Second International Conference on Avian Influenza at France&#039;s Pasteur Institute PARIS, June 1 /PRNewswire-FirstCall/ -- Very low doses of Novavax Inc.&#039;s pandemic influenza vaccine provided protection against a lethal challenge of live H5N1 viruses, according to pre-clinical data...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 22, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-present-friedman-billings-ramsey-cos-2007-growth" hreflang="en">Novavax CEO to Present at Friedman, Billings, Ramsey &amp; Co.&#039;s 2007 Growth Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 22 /PRNewswire-FirstCall/ -- Novavax Inc. Chief Executive Officer Dr. Rahul Singhvi will present at Friedman, Billings, Ramsey &amp;amp; Co.&#039;s 2007 Growth Conference at 3:50 p.m. Eastern Time on Wednesday, May 30 at the Grand Hyatt Hotel, New York, the company announced today. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 11, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-first-quarter-2007-financial-results" hreflang="en">Novavax Reports First Quarter 2007 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 11 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) today reported financial results for the first quarter ended March 31, 2007....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 04, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-present-acumenbiofins-4th-annual-global-healthcare" hreflang="en">Novavax CEO to Present at ACUMENBioFin&#039;s 4th Annual Global Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 4 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) Chief Executive Officer Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 03, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-positive-pre-clinical-study-results-live-virus" hreflang="en">Novavax Reports Positive Pre-Clinical Study Results from Live Virus Challenge to Pandemic Flu Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Ferret Study to be Part of Data Package Required to Begin Clinical Trials ROCKVILLE, Md., May 3 /PRNewswire-FirstCall/ -- Novavax Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 01, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-2007-first-quarter-financial" hreflang="en">Novavax Announces Release Date of 2007 First Quarter Financial Results and Investor Conference Call</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., May 1 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2007 first quarter financial results in a press release to be issued after 7:00 a.m. Eastern Time on May 11, 2007....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 05, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-interim-cfo" hreflang="en">Novavax Appoints Interim CFO</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Jeffrey W. Church Resigns as Chief Financial Officer ROCKVILLE, Md., April 5 /PRNewswire-FirstCall/ -- Novavax Inc. today appointed Len Stigliano as interim Chief Financial Officer to replace Jeffrey W. Church, who is leaving later this month to accept a position with another company....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 02, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-vaccine-provides-robust-immune-response-pre-clinical" hreflang="en">Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data Show</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Study Published in Vaccine Shows Strong Immune Response, Protection Against H9N2 Influenza Strain ROCKVILLE, Md., April 2 /PRNewswire-FirstCall/ -- Novavax Inc.&#039;s virus- like particle (VLP) vaccine triggered a robust immune response and provided protection against the H9N2 strain of avian influenza,...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 14, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-james-robinson-vice-president-technical-and" hreflang="en">Novavax Appoints James Robinson Vice President of Technical and Quality Operations</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 14 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) has appointed James M. Robinson Vice President of Technical and Quality Operations, the company said today....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 14, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-fourth-quarter-and-2006-year-end-financial" hreflang="en">Novavax Reports Fourth Quarter and 2006 Year-End Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 14 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) today announced financial results for the fourth quarter and year ended Dec. 31, 2006....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 08, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-board-directors-elect-john-lambert-executive-chairman" hreflang="en">Novavax Board of Directors Elect John Lambert as Executive Chairman</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Gary C. Evans to Serve as Lead Director ROCKVILLE, Md., March 8 /PRNewswire-FirstCall/ -- (Nasdaq: NVAX) Novavax Inc.&#039;s Board of Directors has elected vaccine expert John Lambert as Executive Chairman of the Board....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 06, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-2006-fourth-quarter-full-year" hreflang="en">Novavax Announces Release Date of 2006 Fourth Quarter, Full Year Financial Results and Investor Conference Call</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 6 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2006 fourth quarter and full-year financial results in a press release to be issued after 7:00 a.m. Eastern Time on March 14, 2007....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 02, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-licenses-new-vlp-technology-university-massachusetts" hreflang="en">Novavax Licenses New VLP Technology From University of Massachusetts Medical School</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., March 2 /PRNewswire-FirstCall/ - Novavax Inc. (Nasdaq: NVAX) announced today that it has entered into a worldwide exclusive agreement to license a new virus-like particle (VLP) technology from the University of Massachusetts Medical School (UMMS) in Worcester....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 21, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/pre-clinical-study-novavaxs-seasonal-influenza-vaccine-published" hreflang="en">Pre-Clinical Study of Novavax&#039;s Seasonal Influenza Vaccine Published in Journal &#039;Vaccine&#039;</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Data Demonstrate Broad, Robust Immune Response to VLP Vaccine ROCKVILLE, Md., Feb. 21 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 07, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-present-bio-ceo-investor-conference" hreflang="en">Novavax CEO to Present at BIO CEO &amp; Investor Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Feb. 7 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) Chief Executive Officer Dr. Rahul Singhvi will present at the BIO CEO &amp;amp; Investor Conference at 12:45 p.m. on Feb. 13 at The Waldorf=Astoria Hotel in New York, the company announced today. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 23, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavaxs-dr-gale-smith-chair-scientific-congress" hreflang="en">Novavax&#039;s Dr. Gale Smith to Chair Scientific Congress</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Jan 23, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax Inc. (Nasdaq: NVAX) said today that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 22, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/new-data-support-novavaxs-pandemic-flu-vaccines" hreflang="en">New Data Support Novavax&#039;s Pandemic Flu Vaccines</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>First Data From Live-Virus Challenge Study Show Robust Immune Response and Cross-Protection in Pre-Clinical Models BALTIMORE, Jan 22, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax, Inc.&#039;s (Nasdaq: NVAX) novel virus-like particle (VLP) vaccines have been shown to be effective in gene...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 17, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-participate-phacilitate-vaccine-forum" hreflang="en">Novavax to Participate in Phacilitate Vaccine Forum</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>ROCKVILLE, Md., Jan. 17 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) today announced the company&#039;s participation in the Phacilitate Vaccine Forum, a three-day conference that begins Monday at the Marriott Waterfront Hotel in Baltimore, MD....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 16, 2007 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-collaborators-significantly-improve-vlp-vaccine" hreflang="en">Novavax and Collaborators Significantly Improve VLP Vaccine for HIV/AIDS</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Plans Under Way to Advance New Vaccine Into Clinical Testing ROCKVILLE, Md., Jan. 16 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) said today that it has significantly enhanced both the quality and purity of its virus-like particle (VLP) vaccine for HIV/AIDS....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 13, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-relocating-corporate-headquarters-maryland" hreflang="en">Novavax Relocating Corporate Headquarters to Maryland</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Research Labs, Business Offices to be Housed Together in State-of-the-Art Facility in Rockville MALVERN, Pa., Dec. 13 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 05, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-present-bmo-nesbitt-burns-healthcare-conference" hreflang="en">Novavax CEO to Present at BMO Nesbitt Burns Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Dec 05, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax Inc. (Nasdaq: NVAX) Chief Executive Officer Dr. Rahul Singhvi will present at the BMO Nesbitt Burns Healthcare Conference on December 6 at the Millennium Broadway Hotel in New York, the company announced today. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 22, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-files-100-million-shelf-registration-statement-0" hreflang="en">Novavax Files $100 Million Shelf Registration Statement</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Nov. 22 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (&quot;SEC&quot;)....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 14, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-third-quarter-2006-financial-results" hreflang="en">Novavax Reports Third Quarter 2006 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Nov 14, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax Inc. (Nasdaq: NVAX), today announced its financial results for the third quarter ended September 30, 2006....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 08, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavaxs-pandemic-influenza-vaccine-candidates-trigger-robust" hreflang="en">Novavax&#039;s Pandemic Influenza Vaccine Candidates Trigger Robust Immune Response In Pre-Clinical Models</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>New Data Presented at World Congress on Vaccines, Immunization and Immunotherapy MONTREAL, Nov....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 07, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-third-quarter-2006-financial" hreflang="en">Novavax Announces Release Date of Third Quarter 2006 Financial Results and Investor Conference Call</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Nov. 7 /PRNewswire-FirstCall/ -- (Nasdaq: NVAX) - Novavax, Inc. today announced that it will report its third quarter financial results in a press release to be issued after 7:00 a.m. EST on Nov. 14, 2006....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 01, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-present-rodman-renshaws-annual-healthcare-conference" hreflang="en">Novavax CEO to Present at Rodman &amp; Renshaw&#039;s Annual Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Nov. 1 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) -- Novavax, Inc. Chief Executive Officer, Dr. Rahul Singhvi, will present at Rodman &amp;amp; Renshaw&#039;s 8th Annual Healthcare Conference on November 7 at the New York Palace Hotel in New York, the company announced today. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 31, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/cdc-evaluate-novavaxs-pandemic-influenza-vaccine-candidate" hreflang="en">CDC TO EVALUATE NOVAVAX&#039;S PANDEMIC INFLUENZA VACCINE CANDIDATE</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>First Opportunity To Test Novel Vaccine Against Live Virus MALVERN, Pa., Oct. 31 /PRNewswire-FirstCall/ -- (Nasdaq: NVAX) - Novavax, Inc. said today the U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 10, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-details-advantages-portable-manufacturing-process-world" hreflang="en">Novavax Details Advantages of Portable Manufacturing Process at World Vaccine Congress</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>LYON, France, Oct. 10 /PRNewswire-FirstCall/ -- Novavax Inc.&#039;s (Nasdaq: NVAX) unique cell culture manufacturing system has the potential to produce up to several million doses of vaccine within six months of an influenza pandemic, the Company said here today at the World Vaccine Congress....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 02, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-names-dr-penny-heaton-chief-medical-officer" hreflang="en">Novavax Names Dr. Penny Heaton Chief Medical Officer</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Oct. 2 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today named Penny Heaton, M.D., to the newly created position of Chief Medical Officer, effective Oct. 9. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 21, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-present-ubs-global-life-sciences-conference" hreflang="en">Novavax CEO to Present at UBS Global Life Sciences Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Sept. 21 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) -- Novavax, Inc. President and Chief Executive Officer, Dr. Rahul Singhvi, will present at the UBS Global Life Sciences Conference on September 26 at the Grand Hyatt Hotel in New York, the company announced today. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 19, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-initiates-pre-clinical-testing-intranasal-influenza" hreflang="en">Novavax Initiates Pre-Clinical Testing of Intranasal Influenza Vaccine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>New Delivery Route May Provide Alternative to Administration by Injection MALVERN, Penn., Sept. 19 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 06, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-elects-dr-tom-monath-board-directors" hreflang="en">Novavax Elects Dr. Tom Monath to Board of Directors</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Sept. 6 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) said today that the company&#039;s board has unanimously elected Dr. Tom Monath to be a new director, effective immediately. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 17, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-names-jeffrey-church-chief-financial-officer" hreflang="en">Novavax Names Jeffrey Church Chief Financial Officer</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Aug. 17 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) said today that Jeffrey Church has been appointed Vice President, Chief Financial Officer and Treasurer, effective September 5, 2006. Mr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 14, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-second-quarter-financial-results" hreflang="en">Novavax Announces Second Quarter Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Aug. 14 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the second quarter ended June 30, 2006....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 02, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-second-quarter-2006-financial" hreflang="en">Novavax Announces Release Date of Second Quarter 2006 Financial Results and Investor Conference Call</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Aug. 2 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its second quarter financial results in a Press Release to be issued after 7:00 a.m. EDT on August 14, 2006....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 31, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-succeeds-making-vaccine-protect-against-new-mutation" hreflang="en">Novavax Succeeds in Making Vaccine to Protect Against New Mutation of Avian Influenza</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Novavax to begin pre-clinical testing immediately MALVERN, Pa., July 31 /PRNewswire-FirstCall/ -- Novavax Inc. (Nasdaq: NVAX) -- Novavax Inc. said today its scientists have succeeded in making a vaccine candidate designed to protect against the H5N1 clade 2 influenza virus....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 18, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-receives-positive-results-pre-clinical-studies-influenza" hreflang="en">Novavax Receives Positive Results From Pre-Clinical Studies of Influenza Vaccines</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Two Key Collaborators Validate Novavax&#039;s Proprietary VLP Technology MALVERN, Pa., July 18 /PRNewswire-FirstCall/ -- Novavax Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 12, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-board-appoints-current-director-audit-committee" hreflang="en">Novavax Board Appoints Current Director to Audit Committee</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Action Resolves Notice Letter from Nasdaq MALVERN, Pa., July 12 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 12, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-names-mariann-caprino-vice-president-corporate" hreflang="en">Novavax Names Mariann Caprino Vice President of Corporate Communications and Investor Relations</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., June 12 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today appointed Mariann Caprino Vice President of Corporate Communications and Investor Relations. A former journalist, Ms....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 08, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-names-executive-director-biologic-product-discovery" hreflang="en">Novavax Names Executive Director of Biologic Product Discovery</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Dr. Kutub Mahmood - An Expert in Virology and Immunology MALVERN, Pa., June 8, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax, Inc. (Nasdaq: NVAX) today announced the appointment of Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 24, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-added-nasdaq-biotech-index" hreflang="en">Novavax Added to NASDAQ Biotech Index</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., May 24, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax, Inc. (Nasdaq: NVAX), said today that it has been added to the NASDAQ Biotechnology Index as of May 19, 2006. Novavax has traded on the exchange since July 10, 2001....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 19, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-esprit-pharma-co-develop-novel-medicine-female" hreflang="en">Novavax and Esprit Pharma to Co-develop Novel Medicine for Female Sexual Desire Disorder</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Esprit Receives North American Marketing Rights MALVERN, Pa., May 19 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 15, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-first-quarter-2006-financial-0" hreflang="en">Novavax Announces Release Date of First Quarter 2006 Financial Results and Investor Conference Call</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., May 5, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its first quarter financial results in a Press Release to be issued after 7:00 a.m. EDT on May 15, 2006....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 15, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-first-quarter-2006-financial-results" hreflang="en">Novavax Announces First Quarter 2006 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., May 15 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced its first quarter 2006 operational and financial results....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 11, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-strengthens-vaccine-development-team-two-new" hreflang="en">Novavax Strengthens Vaccine Development Team with Two New Appointments</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>* Dr. Jinyou Zhang Appointed as Senior Director of Bioprocess R &amp;amp; D * Dr. Niranjan Kumar Appointed as Senior Director of Commercial Manufacturing MALVERN, Pa., May 11 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 10, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-head-pharmaceutical-development-present-micellar" hreflang="en">Novavax Head of Pharmaceutical Development to Present on Micellar Nanoparticle Technology at Particles 2006 Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., May 10 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Robert Lee, Ph.D., Vice President - Pharmaceutical Development, is scheduled to present at the Particles 2006 Conference on Tuesday, May 16, 2006 at 3:30 p.m....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 09, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-rodman-renshaw-3rd-annual-global-healthcare" hreflang="en">Novavax to Present at the Rodman &amp; Renshaw 3rd Annual Global Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., May 9 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that Dr. Rahul Singhvi, President and Chief Executive Officer, is scheduled to present at the Rodman &amp;amp; Renshaw 3rd Annual Global Healthcare Conference on Monday, May 15, 2006 at 4:10 a.m....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 05, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-first-quarter-2006-financial" hreflang="en">Novavax Announces Release Date of First Quarter 2006 Financial Results and Investor Conference Call</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., May 5 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its first quarter financial results in a Press Release to be issued after 7:00 a.m. EDT on May 15, 2006....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 01, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavaxs-head-vaccine-research-participate-who-meeting-develop" hreflang="en">Novavax&#039;s Head Of Vaccine Research To Participate In WHO Meeting To Develop Global Action Plan For Pandemic Influenza</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., May 1, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that its Vice President of Vaccine Research, Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 28, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-board-elects-dr-james-b-tananbaum-director" hreflang="en">Novavax Board Elects Dr. James B. Tananbaum as Director</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- Dr. Tananbaum is Co-founder of Prospect Venture Partners II and III, Theravance, Infinity Pharmaceuticals, and GelTex (acquired by Genzyme) - MALVERN, Pa., April 28 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that its board of directors has elected James B....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 20, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-ubs-global-specialty-pharmaceuticals-conference" hreflang="en">Novavax to Present at UBS Global Specialty Pharmaceuticals Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., April 20 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that Dr. Rahul Singhvi, President and Chief Executive Officer, is scheduled to present at UBS Global Specialty Pharmaceuticals Conference on Monday April 24, 2006 at 12:00 p.m....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 17, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-successfully-completes-additional-vaccine-milestone" hreflang="en">Novavax Successfully Completes Additional Vaccine Milestone</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- Validation of cGMP Biological Manufacturing Facility Complete - MALVERN, Pa., April 17 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 10, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-bio-2006-chicago-annual-international-convention" hreflang="en">Novavax to Present at BIO 2006 Chicago Annual International Convention</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., April 10, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 31, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-bond-holders-elect-convert-70-million-outstanding-notes" hreflang="en">Novavax Bond Holders Elect to Convert $7.0 Million of Outstanding Notes</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., March 31 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 21, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-executes-definitive-agreement-38-million-public-offering" hreflang="en">Novavax Executes Definitive Agreement for $38 Million Public Offering</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., March 21 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has entered into a definitive agreement for a $38 million registered direct offering of 5,205,479 shares of its common stock at a price of $7.30 per share....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 20, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-ceo-present-world-vaccine-congress-2006" hreflang="en">Novavax CEO to Present at World Vaccine Congress 2006</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., March 20 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX), today announced that Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax, is scheduled to make a presentation at the World Vaccine Congress 2006 in Washington, DC on Tuesday, March 21, 2006....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 16, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-receives-additional-government-funding-hivaids-vaccine" hreflang="en">Novavax Receives Additional Government Funding for HIV/AIDS Vaccine Research</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., March 16 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 09, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/us-senator-rick-santorum-r-pa-will-tour-novavax-facility" hreflang="en">U.S. Senator Rick Santorum (R-PA) Will Tour Novavax Facility</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., March 9 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 06, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-bharat-biotech-announce-strategic-alliance-pandemic" hreflang="en">Novavax and Bharat Biotech Announce Strategic Alliance for Pandemic Influenza Vaccine Development</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>HYDERABAD, India and MALVERN, Pa., March 6 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 01, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-fourth-quarter-and-year-end-2005-financial" hreflang="en">Novavax Announces Fourth Quarter and Year-End 2005 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., March 1 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced its fourth quarter and year-end 2005 financial results....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 28, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-strategic-alliance-pacificgmp-pandemic" hreflang="en">Novavax Announces Strategic Alliance With PacificGMP on Pandemic Influenza Vaccine Production Technologies</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Feb 28, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 27, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-20-million-common-stock-offering-kleiner" hreflang="en">Novavax Announces $20 Million Common Stock Offering to Kleiner Perkins Caufield &amp; Byers and Prospect Venture Partners</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Feb. 27 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has entered into a definitive agreement for a $20 million registered direct offering of 4,597,701 shares of its common stock to Kleiner Perkins Caufield &amp;amp; Byers and Prospect Venture Partners....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 21, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-fourth-quarter-and-year-end-2005" hreflang="en">Novavax Announces Release Date of Fourth Quarter and Year-End 2005 Financial Results and Investor Conference Call</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Feb 21, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that it will report its fourth quarter and year-end 2005 financial results in a Press Release to be issued after 7:00 a.m. ET on March 1, 2006....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 15, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-research-collaboration-university-pittsburgh" hreflang="en">Novavax Announces Research Collaboration With the University of Pittsburgh School of Medicine</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- Efficacy of Seasonal and Pandemic Influenza VLP Vaccines Explored - MALVERN, PA, February 15, 2006 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 14, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-bio-ceo-investor-conference" hreflang="en">Novavax to Present at BIO CEO &amp; Investor Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Feb. 14 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Dr. Rahul Singhvi, President and Chief Executive Officer, is scheduled to present at the BIO CEO &amp;amp; Investor Conference in New York City on Wednesday, February 15, 2006 at 10:30 a.m....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 02, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-new-vice-president-vaccine-research" hreflang="en">Novavax Appoints New Vice President of Vaccine Research</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Feb. 2 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced the appointment of Rick A. Bright, Ph. D. to the newly created position of Vice President, Vaccine Research. Dr. Bright will report directly to Dr. Rahul Singhvi, President and CEO of Novavax....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 10, 2006 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-university-maryland-avian-flu-what-can-we-do" hreflang="en">Novavax to Present at the University of Maryland &#039;Avian Flu: What Can We Do?&#039; Symposium</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Jan. 10 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 23, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-receives-80-million-cash-payment-estrasorbr" hreflang="en">Novavax Receives $8.0 Million Cash Payment on ESTRASORB(R)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Dec. 23 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has received the second cash payment in the amount of $8.0 million related to its license agreement with Esprit Pharma, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 22, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-files-100-million-shelf-registration-statement" hreflang="en">Novavax Files $100 Million Shelf Registration Statement</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Dec. 22 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has filed a universal shelf registration statement with the Securities and Exchange Commission....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 08, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-third-quarter-2005-financial-results" hreflang="en">Novavax Announces Third Quarter 2005 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Nov. 8 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX), today announced its third quarter financial and operational results....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 04, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-rodman-renshaw-techvest-7th-annual-healthcare" hreflang="en">Novavax to Present at Rodman &amp; Renshaw Techvest 7th Annual Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Nov. 4 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Mr. Gary C. Evans, Chairman and Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 04, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-third-quarter-2005-financial" hreflang="en">Novavax Announces Release Date of Third Quarter 2005 Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Nov. 4 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) will report its third quarter 2005 financial results in a press release to be issued after 7:00 a.m. (EST) on November 8, 2005....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 02, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-executes-definitive-agreements-18-million-public" hreflang="en">Novavax Executes Definitive Agreements for $18 Million Public Offering</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Nov. 2 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has entered into definitive agreements to raise $18 million through the issuance of 4,186,047 shares of its common stock at a price of $4.30 per share....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 27, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-bond-holders-elect-convert-6-million-outstanding-notes" hreflang="en">Novavax Bond Holders Elect to Convert $6 Million of Outstanding Notes</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Oct. 27 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 24, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-ce-unterberg-towbin-life-sciences-conference" hreflang="en">Novavax to Present at the C.E. Unterberg, Towbin Life Sciences Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Oct. 24 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a specialty biopharmaceutical company, today announced that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the C.E....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 18, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-conference-call" hreflang="en">Novavax Announces Conference Call</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Oct. 18 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a specialty biopharmaceutical company, today announced the Company will hold a conference call tomorrow morning at 10 am (EST) to discuss a significant transaction on the Company&#039;s primary product, ESTRASORB(R)....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 18, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-completes-estrasorb-partnership" hreflang="en">Novavax Completes ESTRASORB Partnership</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Oct. 18 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that it has entered into a definitive license and supply agreement on ESTRASORB(R) (estradiol topical emulsion) with Esprit Pharma, a private specialty pharmaceutical company based in East Brunswick, NJ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 13, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-2005-bio-investorforum" hreflang="en">Novavax to Present at the 2005 Bio InvestorForum</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Oct. 13 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a specialty biopharmaceutical company, today announced that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 23, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-closes-sale-non-core-product-assets" hreflang="en">Novavax Closes Sale of Non-Core Product Assets</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Sept. 23 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that it has completed the sale of certain products deemed non-core to Novavax to Pharmelle LLC located in Gilbert, AZ....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 13, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-strategic-alliance-pandemic-influenza-vaccine" hreflang="en">Novavax Announces Strategic Alliance on Pandemic Influenza Vaccine Production Technologies</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Sept. 13 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 08, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-new-vice-president-pharmaceutical-development-0" hreflang="en">Novavax Appoints New Vice President of Pharmaceutical Development</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Sept. 8 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced the appointment of Robert W. Lee, Ph.D. to the position of Vice President, Pharmaceutical Development. Dr. Lee will report directly to Dr. Rahul Singhvi, President and CEO. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 25, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reports-positive-preclinical-results-its-novel-vaccine" hreflang="en">Novavax reports positive preclinical results on its novel vaccine for pandemic influenza</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NASDAQ symbol: NVAX MALVERN, PA, Aug 25, 2005 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX), a specialty biopharmaceutical company, today reported preclinical results on the Company&#039;s novel Virus-Like Particle (VLP) influenza vaccine. Novavax&#039;s biological group led by Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 09, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-second-quarter-results" hreflang="en">Novavax announces second quarter results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NASDAQ symbol: NVAX MALVERN, PA, Aug. 9 /PRNewswire-FirstCall/ - Novavax, Inc. (Nasdaq: NVAX), a specialty biopharmaceutical company, today announced its second quarter financial and operational results....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 09, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-new-president-ceo-and-board-member" hreflang="en">Novavax Announces New President, CEO and Board Member</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NASDAQ symbol: NVAX MALVERN, PA, Aug. 9 /PRNewswire-FirstCall/ - Novavax, Inc. (Nasdaq: NVAX), a specialty biopharmaceutical company, announced Dr. Rahul Singhvi has been appointed President and CEO of Novavax effective today. He has also been elected a director of the Company. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 03, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-second-quarter-financial-results" hreflang="en">Novavax announces release date of second quarter financial results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NASDAQ symbol: NVAX MALVERN, PA, Aug. 3 /PRNewswire-FirstCall/ - Novavax, Inc., (Nasdaq: NVAX) a specialty pharmaceutical company, will report its second quarter financial results in a release to be issued after 7:00 a.m. (EDT) on August 9, 2005....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 05, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-raises-4000000-equity-offering" hreflang="en">Novavax raises $4,000,000 in equity offering</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- PARTNERING FOR ESTRASORB CONTINUES TO PROGRESS - NASDAQ symbol: NVAX MALVERN, PA, July 5 /PRNewswire-FirstCall/ - Novavax, Inc. (Nasdaq: NVAX), a specialty biopharmaceutical company, today announced that it has completed a financing resulting in gross proceeds of $4,000,000....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 17, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-bio-2005-forum" hreflang="en">Novavax to present at BIO 2005 Forum</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- Company also presents drug delivery and vaccine posters - NASDAQ symbol: NVAX MALVERN, PA, June 17, 2005 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX), a specialty biopharmaceutical company, today announced that Nelson M....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 08, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-expands-pipeline-pre-clinical-results-two-new-compounds" hreflang="en">Novavax expands pipeline with pre-clinical results for two new compounds</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NASDAQ symbol: NVAX MALVERN, PA, June 8 /PRNewswire-FirstCall/ - Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 24, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-positive-pre-clinical-results" hreflang="en">Novavax Announces Positive Pre-Clinical Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>- Achieves Target Blood Levels for Non-Hormonal Drugs Using MNP Drug Delivery Technology - MALVERN, PA, May 24 /PRNewswire-FirstCall/ - Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 18, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-ubs-global-pharmaceuticals-conference" hreflang="en">Novavax to present at the UBS Global Pharmaceuticals Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NASDAQ symbol: NVAX MALVERN, PA, May 18, 2005 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc., (Nasdaq: NVAX) a specialty biopharmaceutical company, today announced that Nelson M. Sims, President and Chief Operating Officer, will be presenting at the 2005 UBS Global Pharmaceuticals Conference....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 10, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-first-quarter-results" hreflang="en">Novavax announces first quarter results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NASDAQ symbol: NVAX MALVERN, PA, May 10 /PRNewswire-FirstCall/ - Novavax, Inc. (Nasdaq: NVAX), a specialty biopharmaceutical company, today announced its first quarter financial and operational results....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 09, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-agreement-reduce-estrasorb-manufacturing-costs" hreflang="en">Novavax announces agreement to reduce ESTRASORB manufacturing costs</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NASDAQ symbol: NVAX MALVERN, PA, May 9 /PRNewswire-FirstCall/ - Novavax, Inc., (Nasdaq: NVAX) a specialty biopharmaceutical company, today announced that it has restructured its relationship with Cardinal Health, Inc. (NYSE: CAH)....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 03, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-first-quarter-results" hreflang="en">Novavax announces release date of first quarter results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>NASDAQ symbol: NVAX MALVERN, Pa., May 3, 2005 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc., (Nasdaq: NVAX) a specialty biopharmaceutical company, will report its first quarter 2005 financial results in a release to be issued at 7:00 a.m. (EDT) on May 10th, 2005....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 14, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-world-vaccine-congress-2005" hreflang="en">Novavax to present at the World Vaccine Congress 2005</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, PA, April 14 /PRNewswire-FirstCall/ - Novavax, Inc., (Nasdaq: NVAX - News) a specialty biopharmaceutical company, today announced that Dr. Louis Potash, Director of Vaccine Technologies at Novavax, will be presenting at the World Vaccine Congress 2005....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 05, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/change-directors-or-principal-officers-financial-statements-and" hreflang="en">Change in Directors or Principal Officers, Financial Statements and Exhibits</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On April 4, 2005, Novavax announced changes to it&#039;s Board of Directors and senior management team. Gary C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 04, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-board-directors-elects-gary-c-evans-chairman-and" hreflang="en">Novavax Board of Directors Elects Gary C. Evans Chairman and Promotes Rahul Singhvi to Senior Vice-President and Chief Operating Officer</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, PA, April 4 /PRNewswire-FirstCall/ - Novavax, Inc. (Nasdaq: NVAX - News), a specialty biopharmaceutical company, today announced changes to its Board of Directors and senior management team. Effective today, Gary C....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 04, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-alternate-slate-directors-has-been-rescinded" hreflang="en">Novavax Announces Alternate Slate of Directors Has Been Rescinded</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, PA, April 4 /PRNewswire-FirstCall/ - Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 29, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-present-stephens-nanotechnology-conference" hreflang="en">Novavax to present at the Stephens Nanotechnology conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, PA, March 29 /PRNewswire-FirstCall/ - Novavax, Inc., (Nasdaq: NVAX - News) a specialty biopharmaceutical company, today announced that Dr. Rahul Singhvi, Vice-President Pharmaceutical Development and Manufacturing Operations, will be presenting at the Stephens Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 22, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/financial-statements-and-exhibits" hreflang="en">Financial Statements and Exhibits</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Item 9.01. Financial Statements and Exhibits. On March 21, 2005, Novavax, Inc. implemented a measure to control expenses by restructuring the size of its sales force....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 21, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-moves-ahead-cost-rationalization-plan" hreflang="en">Novavax moves ahead with cost rationalization plan</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, PA, March 21 /PRNewswire-FirstCall/ - Novavax, Inc. (Nasdaq: NVAX - News), a specialty biopharmaceutical company, today announced additional measures to control expenses by reducing the size of its sales force....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 16, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-partners-ranbaxy-evaluate-micellar-nanoparticle" hreflang="en">Novavax partners with Ranbaxy to evaluate micellar nanoparticle technology applications</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, PA, March 16 /PRNewswire-FirstCall/ - Novavax, Inc. (Nasdaq: NVAX - News), a specialty biopharmaceutical company, and Ranbaxy Laboratories, Inc., have entered into an agreement to evaluate a new transdermal product (this is a new product and is not related to ESTRASORB®)....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 14, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-fourth-quarter-and-fiscal-2004-results" hreflang="en">Novavax announces fourth quarter and fiscal 2004 results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, PA, March 14 /PRNewswire-FirstCall/ - Novavax, Inc., (Nasdaq: NVAX - News) a specialty biopharmaceutical company, today announced financial results for the fourth quarter and 2004 fiscal year....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 14, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-files-sec-form-8-ka-change-directors-or-principal" hreflang="en">NOVAVAX INC Files SEC form 8-K/A, Change in Directors or Principal Officers</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. (b) On March 9, 2005, Ronald H....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 01, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-release-date-fourth-quarter-and-2004-year-end" hreflang="en">Novavax Announces Release Date of Fourth Quarter and 2004 Year End Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., March 1 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX - News), a specialty pharmaceutical company, will report its fourth quarter and 2004 year end financial results in a release to be issued after 4:00 p.m. (EST) on March 14, 2005....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 04, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-receives-sars-vaccine-funding-nih" hreflang="en">Novavax Receives SARS Vaccine Funding From NIH</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Feb. 4 /PRNewswire-FirstCall/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 12, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-updates-2005-first-half-milestones" hreflang="en">Novavax Updates 2005 First Half Milestones</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Jan. 12 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ), a specialty pharmaceutical company, today updated the market on its expected milestones for the first half of 2005 and the milestone achievements of 2004....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 10, 2005 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavaxs-estrasorb-product-referenced-nbcs-today-show" hreflang="en">Novavax&#039;s ESTRASORB Product Referenced on NBC&#039;s &#039;Today Show&#039;</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Jan. 10 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX), a specialty pharmaceutical company, today announced that the NBC morning news show &quot;NBC Today&quot; this morning referenced Novavax&#039;s ESTRASORB(R) product, a topical estrogen therapy. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Dec 06, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-updates-clinical-strategy-testosterone-therapy-androsorb" hreflang="en">Novavax Updates Clinical Strategy for Testosterone Therapy ANDROSORB </a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Dec. 6 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) -- In light of the recent FDA advisory panel recommendation for Procter &amp;amp; Gamble&#039;s Intrinsa(R) testosterone patch, Novavax reaffirms its strategy for the development of ANDROSORB(R)....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 08, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-files-sec-form-10-q-quarterly-report" hreflang="en">NOVAVAX INC Files SEC form 10-Q, Quarterly Report</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>The following discussion may contain statements that are not purely historical. Certain statements contained herein or as may otherwise be incorporated by reference herein constitute &quot;forward-looking statements&quot; within the meaning of the Private Securities Litigation Reform Act of 1995....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 04, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/form-8-ka-novavax-inc" hreflang="en">Form 8-K/A for NOVAVAX INC </a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>(c) On October 28, 2004, Susan Bayh was appointed to the Novavax, Inc. Board of Directors. Ms. Bayh will serve on Novavax&#039;s Compensation Committee and Nominating and Corporate Governance Committee....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 01, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/reminder-novavax-inc-report-third-quarter-2004-results-november" hreflang="en">Reminder: Novavax, Inc. to Report Third Quarter 2004 Results on November 3, 2004 and Host November 4 Webcast to Provide Update on Drug Delivery Product Development and Vaccine Pipeline </a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Nov. 1 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) a specialty pharmaceutical company is scheduled to report financial results for the third quarter 2004 on Wednesday, November 3, 2004, after the market close....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 29, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-files-sec-form-8-k-other-events" hreflang="en">NOVAVAX INC Files SEC form 8-K, Other Events</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>On October 28, 2004, the Company announced the appointment of Susan B. Bayh as a Director to the Novavax, Inc. Board of Directors....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 28, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-susan-b-bayh-board-directors" hreflang="en">Novavax Appoints Susan B. Bayh to Board of Directors </a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Oct. 28 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced the appointment of Susan B. Bayh to the Company&#039;s Board of Directors. Bayh, 44, is a new addition to the Board and brings the number of independent directors to six and the total director count to nine....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 26, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-ce-unterberg-towbin-specialty-pharmaceutical" hreflang="en">Novavax, Inc. to Present at C.E. Unterberg Towbin Specialty Pharmaceutical Conference </a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Oct. 26 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Nelson M....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 21, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-hosts-conference-call-provide-corporate-update" hreflang="en">Novavax, Inc. Hosts Conference Call to Provide Corporate Update</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Oct. 21 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) a specialty pharmaceutical company will hold a conference call today to provide an update on the state of its business, including the recent launch of ESTRASORB(R), a topical estrogen therapy....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 27, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-completes-relocation-corporate-headquarters-malvern" hreflang="en">Novavax, Inc. Completes Relocation of Corporate Headquarters to Malvern, Pennsylvania</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>MALVERN, Pa., Sept. 27 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced the opening of its new corporate headquarters in the Great Valley Corporate Center, Malvern, Pennsylvania. The Company&#039;s new corporate address is 508 Lapp Road, Malvern, PA 19355....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 18, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-clarifies-recent-form-s-3-registration-statement" hreflang="en">Novavax, Inc. Clarifies Recent Form S-3 Registration Statement Filings and Provides Update on ESTRASORB Prescription Data</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Aug. 18 /PRNewswire-FirstCall/ -- NOVAVAX, INC....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 09, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-second-quarter-2004-results" hreflang="en">Novavax, Inc. Announces Second Quarter 2004 Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Aug. 9 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX ) today announced its financial results for the second quarter ended June 30, 2004. Total revenues for the second quarter rose 32% to $3.0 million compared to second quarter 2003 revenues of $2.3 million....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 06, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-relocation-corporate-headquarters" hreflang="en">Novavax, Inc. Announces Relocation of Corporate Headquarters </a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Aug. 6 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced that it will relocate its corporate headquarters to Malvern, Pennsylvania to consolidate its women&#039;s health and drug delivery business....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 28, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-banc-america-securities-specialty" hreflang="en">Novavax, Inc. to Present at Banc of America Securities Specialty Pharmaceutical Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., July 28 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Nelson M....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 26, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-second-quarter-2004-financial-results-monday" hreflang="en">NOVAVAX To Report Second Quarter 2004 Financial Results On Monday, August 9, 2004</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., July 26 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) is scheduled to report financial results for the second quarter 2004 on Monday, August 9, 2004, after the market close....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 19, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-reacquire-all-rights-estrasorbr-king-pharmaceuticals" hreflang="en">Novavax to Reacquire All Rights to ESTRASORB(R) From King Pharmaceuticals</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md. and BRISTOL, Tenn., July 19 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) and KING PHARMACEUTICALS, INC....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 01, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-provides-update-hiv-vaccine-programs" hreflang="en">Novavax, Inc. Provides Update on HIV Vaccine Programs</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., July 1 /PRNewswire-FirstCall/ -- NOVAVAX, INC....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 22, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-enters-final-phase-its-commercial-launch-estrasorbr" hreflang="en">Novavax Enters Final Phase of Its Commercial Launch of ESTRASORB(R)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., June 22 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has entered the final phase of its commercial launch of ESTRASORB(R) (estradiol topical emulsion), the first and only FDA-approved topical emulsion for estrogen therapy....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 21, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-ubs-warburg-global-specialty-1" hreflang="en">Novavax, Inc. to Present at UBS Warburg Global Specialty Pharmaceuticals Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., May 21 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Denis M....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 05, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-first-quarter-2004-results" hreflang="en">Novavax, Inc. Announces First Quarter 2004 Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Second Quarter Launch of ESTRASORB(R) Continues COLUMBIA, Md., May 5 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) Today Announced Its Financial Results For The First Quarter Ended March 31, 2004....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 28, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-first-quarter-2004-financial-results-wednesday" hreflang="en">Novavax to Report First Quarter 2004 Financial Results on Wednesday, May 5, 2004</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., April 28 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) is scheduled to report financial results for the first quarter 2004 on Wednesday, May 5, 2004, after the market close....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 21, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavaxs-launch-estrasorbr-underway" hreflang="en">Novavax&#039;s Launch of ESTRASORB(R) Underway</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., April 21 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced that the planned second quarter 2004 launch of ESTRASORB(R), the Company&#039;s proprietary topical emulsion for estrogen therapy, is underway, the product having fulfilled FDA requirements....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 19, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-added-merrill-lynch-nanotech-index" hreflang="en">Novavax Added to Merrill Lynch Nanotech Index</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., April 19 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that its stock has been added to the Merrill Lynch Nanotech Index, effective today, April 19, 2004....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 14, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-president-and-ceo-nelson-m-sims-be-featured-guest" hreflang="en">Novavax President and CEO Nelson M. Sims to Be Featured Guest on Biotech Today Radio Program</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., April 14 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced that President and CEO Nelson M. Sims is scheduled to appear as a featured guest on Biotech Today, a New Media Internet radio show carried by World Talk Radio....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 07, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-appoints-new-vice-president-pharmaceutical-development" hreflang="en">Novavax Appoints New Vice President of Pharmaceutical Development and Manufacturing Operations</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., April 7 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced the appointment of Rahul Singhvi, D.Sc. to the newly created position of Vice President, Pharmaceutical Development and Manufacturing Operations. Dr. Singhvi will report to Nelson M....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 10, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-fourth-quarter-and-year-end-2003-results" hreflang="en">Novavax, Inc. Announces Fourth Quarter and Year End 2003 Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Prepares for Second Quarter Launch of ESTRASORB(R) COLUMBIA, Md., March 10 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today announced financial results for the fourth quarter and year ended December 31, 2003....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 08, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-comments-estrogen-alone-arm-womens-health-initiative" hreflang="en">Novavax, Inc. Comments on Estrogen-Alone Arm of Women&#039;s Health Initiative Study</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., March 8 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today commented on the preliminary findings from the estrogen-alone study arm of the Women&#039;s Health Initiative (WHI) Study....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 20, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-bio-ceo-and-investor-conference-2004" hreflang="en">Novavax, Inc. to Present at BIO CEO and Investor Conference 2004</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Feb. 20 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced that Nelson M....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 19, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-fourth-quarter-2003-financial-results-wednesday" hreflang="en">Novavax to Report Fourth Quarter 2003 Financial Results on Wednesday, March 10, 2004</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Feb. 19 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) is scheduled to report financial results for the fourth quarter 2003 on Wednesday, March 10, 2004, after the market close....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 13, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-appoints-raymond-j-hage-jr-vice-president-marketing" hreflang="en">Novavax, Inc. Appoints Raymond J. Hage, Jr. as Vice President, Marketing</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Jan. 13 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced that it has appointed Raymond J. Hage, Jr. to the position of Vice President, Marketing, effective January 5, 2004. Mr. Hage will report to Ford R....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jan 13, 2004 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-appoints-gale-e-smith-phd-vice-president-vaccine" hreflang="en">Novavax, Inc. Appoints Gale E. Smith, Ph.D. as Vice President, Vaccine Development</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Jan. 13 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced that it has appointed Gale E. Smith, Ph.D. to the new position of Vice President, Vaccine Development, effective January 5, 2004. Dr. Smith will report to Nelson M....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 26, 2003 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-extension-fda-review-time-estrasorbtm" hreflang="en">Novavax, Inc. Announces Extension of FDA Review Time for Estrasorb(TM)</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>To Hold Conference Call at 9:00 AM ET COLUMBIA, Md., Jun 26, 2003 /PRNewswire-FirstCall via COMTEX/ -- NOVAVAX, INC....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 29, 2003 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-ubs-warburg-global-specialty-pharmaceuticals" hreflang="en">Novavax, Inc. to Present at UBS Warburg Global Specialty Pharmaceuticals Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Conference Presentation May be Accessed via Live Webcast COLUMBIA, Md., May 29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Mitchell J....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 13, 2003 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-2003-first-quarter-results" hreflang="en">Novavax, Inc. Announces 2003 First Quarter Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., May 13 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced financial results for the first quarter ended March 31, 2003. Total revenues for the first quarter of 2003 were $1.2 million compared to first quarter 2002 revenues of $5.7 million....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 05, 2003 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-first-quarter-2003-financial-results-wednesday" hreflang="en">Novavax to Report First Quarter 2003 Financial Results on Wednesday, May 14, 2003</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., May 5, 2003 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) is scheduled to report financial results for the first quarter 2003 on Wednesday, May 14, 2003, prior to the market open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 22, 2003 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-cibc-world-markets-annual-biotechnology" hreflang="en">Novavax, Inc. to Present at CIBC World Markets Annual Biotechnology &amp; Specialty Pharmaceuticals Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>Conference Presentation May be Accessed via Live Webcast COLUMBIA, Md., Apr 22, 2003 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that Mitchell J....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 19, 2003 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-2002-fourth-quarter-and-year-end-results" hreflang="en">Novavax, Inc. Announces 2002 Fourth Quarter and Year End Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Mar 19, 2003 /PRNewswire-FirstCall via Comtex/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced financial results for the fourth quarter and year ended December 31, 2002....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 13, 2003 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-fourth-quarter-and-year-end-2002-financial" hreflang="en">Novavax to Report Fourth Quarter and Year End 2002 Financial Results On Wednesday, March 19, 2003</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Mar 13, 2003 /PRNewswire-FirstCall via COMTEX/ -- NOVAVAX, INC. (Nasdaq: NVAX) is scheduled to report financial results for the fourth quarter and year end 2002 on Wednesday, March 19, 2003, prior to the market open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 18, 2003 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-completes-166-million-financing" hreflang="en">Novavax, Inc. Completes $16.6 Million Financing</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Feb 18, 2003 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it had completed the private placement of 4,750,000 common shares at $3.50 per share to SJ Strategic Investments LLC, for total proceeds from the share sale of $16,625,000....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 12, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-2002-third-quarter-results" hreflang="en">Novavax, Inc. Announces 2002 Third Quarter Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Nov. 12 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced financial results for the third quarter ended September 30, 2002. Total revenues for the third quarter of 2002 were $2.5 million compared to third quarter 2001 revenues of $5.0 million....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 12, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-incs-new-drug-application-estrasorbtm-novel-transdermal" hreflang="en">Novavax, Inc.&#039;s New Drug Application for ESTRASORB(TM), a Novel Transdermal, Topical Estrogen Replacement Therapy, Accepted for Review by the FDA</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Nov. 12 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for ESTRASORB(TM) for review....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Nov 06, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-third-quarter-2002-financial-results-tuesday" hreflang="en">Novavax to Report Third Quarter 2002 Financial Results on Tuesday, November 12, 2002</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Nov. 6 /PRNewswire-FirstCall/ -- NOVAVAX, INC. (Nasdaq: NVAX) is scheduled to report financial results for the third quarter 2002 on Tuesday, November 12, 2002, prior to the market open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 31, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-cibc-world-markets-thirteenth-annual-health" hreflang="en">Novavax, Inc. to Present at CIBC World Markets Thirteenth Annual Health Care Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Oct 31, 2002 /PRNewswire-FirstCall via COMTEX/ -- - Conference Presentation May be Accessed Via Live Webcast - Novavax, Inc. (Nasdaq: NVAX) today announced that Mitchell J....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 16, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-ranked-100th-fastest-growing-technology-company" hreflang="en">Novavax, Inc. Ranked 100th Fastest Growing Technology Company in North America on the 2002 Deloitte &amp; Touche Technology Fast 500</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Oct 16, 2002 /PRNewswire-FirstCall via COMTEX/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced that it ranked Number 100 on the 2002 Deloitte &amp;amp; Touche Technology Fast 500, a ranking of the 500 fastest growing technology companies in North America....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Oct 04, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/results-phase-iii-clinical-trial-reveal-estrasorbtm-estradiol" hreflang="en">Results of Phase III Clinical Trial Reveal Estrasorb(TM) (Estradiol Topical Emulsion) Is Effective in Reducing Vasomotor Symptoms in Post Menopausal Women</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>CHICAGO, Oct 4, 2002 /PRNewswire via COMTEX/ -- Clinical Response is Assessed Patient Preference Data From After An Earlier Trial is also Reported At NAMS Meeting Results from a randomized, double-blind, Phase III clinical trial in postmenopausal women presented today at the North American Menopause...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 16, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-comments-e-selectin-tolerogen-treatment-nih-prevents" hreflang="en">Novavax Comments that E-Selectin Tolerogen Treatment by NIH Prevents Strokes In Animals</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Sep 16, 2002 /PRNewswire-FirstCall via COMTEX/ -- NOVAVAX, INC. (Nasdaq: NVAX) today commented on the results from a published report in the professional journal Stroke, released on September 5, 2002. Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Sep 09, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-submits-new-drug-application-estrasorbtm-novel" hreflang="en">Novavax, Inc. Submits New Drug Application for ESTRASORB(TM), a Novel Transdermal, Topical Estrogen Replacement Therapy</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Sep 09, 2002 /PRNewsire-FirstCall via Comtex/ -- John Spears Steps Down As President and CEO, Company Initiates Executive Search for a Replacement NOVAVAX, INC. (Nasdaq: NVAX) today announced that on September 9, 2002 the Company submitted a New Drug Application (NDA) with the U.S....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 12, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-2002-second-quarter-results" hreflang="en">Novavax, Inc. Announces 2002 Second Quarter Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Aug 12, 2002 /PRNewsire-FirstCall via Comtex/ -- Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the second quarter ended June 30, 2002. Total revenues for the second quarter of 2002 were $4.7 million compared to second quarter 2001 revenues of $7.9 million....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 09, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-board-directors-adopts-stockholder-rights-plan" hreflang="en">Novavax, Inc. Board Of Directors Adopts Stockholder Rights Plan</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Aug 09, 2002 /PRNewsire-FirstCall via Comtex/ -- Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Aug 06, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-second-quarter-2002-financial-results-monday" hreflang="en">Novavax to Report Second Quarter 2002 Financial Results On Monday, August 12, 2002</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Aug 6, 2002 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) is scheduled to report financial results for the second quarter 2002 on Monday, August 12, 2002, prior to the market open....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 17, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-announces-co-promotion-agreement-ferndale-laboratories" hreflang="en">Novavax Announces Co-Promotion Agreement With Ferndale Laboratories, Inc.</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Jul 17, 2002 /PRNewswire-FirstCall via COMTEX/ -- Sales Force to Add Analpram HC(R) to Products Targeted at OB/GYNs Novavax, Inc. (Nasdaq: NVAX) today announced a co-promotion agreement with privately held Ferndale Laboratories, Inc. of Ferndale, Michigan....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jul 11, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-comments-recent-hormone-replacement-therapy-study" hreflang="en">Novavax, Inc. Comments on Recent Hormone Replacement Therapy Study</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Jul 11, 2002 /PRNewswire-FirstCall via COMTEX/ -- The Women&#039;s Health Initiative Announcement Only Refers to Oral Combination Hormone Replacement Therapy. These Results Cannot Be Extrapolated to Low Dose Estrogen Topical Therapy. Novavax, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 27, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-closes-10-million-convertible-note-financing" hreflang="en">Novavax, Inc. Closes $10 Million Convertible Note Financing</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Jun 27, 2002 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it has received $10.0 million through the sale of a convertible note to King Pharmaceuticals, Inc....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 10, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-and-idm-announce-manufacturing-agreement" hreflang="en">Novavax and IDM Announce Manufacturing Agreement</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md. and PARIS, Jun 10, 2002 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) and Immuno-Designed Molecules S.A. (IDM), Paris, France, today announced a multi-year manufacturing agreement....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Jun 05, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-ubs-warburg-global-specialty-0" hreflang="en">Novavax, Inc. to Present at UBS Warburg Global Specialty Pharmaceuticals Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Jun 5, 2002 /PRNewswire-FirstCall via COMTEX/ -- - Conference Presentation May be Accessed via Live Webcast - NOVAVAX, INC. (Nasdaq: NVAX) today announced that Dr. Denis M....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 09, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-2002-first-quarter-results" hreflang="en">Novavax, Inc. Announces 2002 First Quarter Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., May 9, 2002 /PRNewswire-FirstCall via COMTEX/ -- Novavax, Inc. (Nasdaq: NVAX) today announced financial results for the first quarter ended March 31, 2002....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 08, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-deutsche-banc-alex-brown-health-care" hreflang="en">Novavax, Inc. to Present at Deutsche Banc Alex Brown Health Care Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., May 8, 2002 /PRNewswire-FirstCall via COMTEX/ -- Conference Presentation May Be Accessed Via Live Webcast NOVAVAX, INC. (Nasdaq: NVAX) today announced that John A....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 06, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-report-first-quarter-2002-financial-results-thursday-may" hreflang="en">Novavax to Report First Quarter 2002 Financial Results on Thursday, May 9, 2002</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., May 6, 2002 /PRNewswire-FirstCall via COMTEX/ -- NOVAVAX, INC. (Nasdaq: NVAX) is scheduled to report financial results for the first quarter 2002 on Thursday, May 9, 2002 after the market close....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">May 01, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-cibc-world-markets-annual-biotechnology-0" hreflang="en">Novavax, Inc. to Present at CIBC World Markets Annual Biotechnology &amp; Specialty Pharmaceuticals Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., May 1, 2002 /PRNewswire-FirstCall via COMTEX/ -- - Conference Presentation May be Accessed via Live Webcast - NOVAVAX, INC. (Nasdaq: NVAX) today announced that John A....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 24, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-receives-comments-fda" hreflang="en">Novavax, Inc. Receives Comments From The FDA</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Apr 24, 2002 /PRNewswire-FirstCall via COMTEX/ -- To Hold Conference Call Thursday, April 25 At 9:00 AM ET Novavax, Inc. (Nasdaq: NVAX) today announced that the Food and Drug Administration (FDA) has completed its review of the Estrasorb(TM) New Drug Application (NDA)....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 15, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-suntrust-robinson-humphreys-31st-annual" hreflang="en">Novavax, Inc. To Present At Suntrust Robinson Humphrey&#039;s 31st Annual Institutional Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Apr 15, 2002 /PRNewswire-FirstCall via COMTEX/ -- - Conference Presentation Will Be Webcast - Novavax, Inc. (Nasdaq: NVAX) today announced that Dr....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Apr 12, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-recent-management-appointments" hreflang="en">Novavax, Inc. Announces Recent Management Appointments</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Apr 12, 2002 /PRNewswire-FirstCall via COMTEX/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced several recent management appointments. Marvin A. Heuer, MD was named Vice President Scientific Affairs, Ann P. McGeehan, Esq. was added as Novavax&#039;s General Counsel and Nita U....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 27, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-initiates-combination-study-androsorbtm-and" hreflang="en">Novavax, Inc. Initiates Combination Study of ANDROSORB(TM) and ESTRASORB(TM) In Hormone Deficient Women</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Mar 27, 2002 /PRNewswire-FirstCall via COMTEX/ -- Study to Look at Testosterone and Estradiol in Combination NOVAVAX, INC....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 22, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-presents-results-phase-iii-clinical-trial-using" hreflang="en">Novavax Presents Results of a Phase III Clinical Trial Using ESTRASORB(TM) At Society for Gynecologic Investigation Meeting</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>LOS ANGELES, Mar 22, 2002 /PRNewswire-FirstCall via COMTEX/ -- Study With Investigational Drug Showed Symptom Relief in Postmenopausal Women NOVAVAX, INC....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 19, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/results-phase-iii-clinical-trail-using-estrasorbtm-estradiol" hreflang="en">Results of a Phase III Clinical Trail Using Estrasorb(TM) (Estradiol Topical Emulsion) Reported at SGI</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>LOS ANGELES, March 22 /PRNewswire/ -- A randomized, double-blind, Phase III, placebo-controlled clinical trial in postmenopausal women presented today at the Society for Gynecologic Investigation&#039;s 49th Annual Scientific Meeting, showed patients using Estrasorb (estradiol topical emulsion) experienc...<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Mar 06, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-salomon-smith-barney-2nd-annual-specialty" hreflang="en">Novavax, Inc. to Present at Salomon Smith Barney 2nd Annual Specialty Pharmaceuticals Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Mar 6, 2002 /PRNewswire-FirstCall via COMTEX/ -- Conference Presentation May be Accessed via Live Webcast NOVAVAX, INC. (Nasdaq: NVAX) today announced that John A....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 26, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-present-lehman-brothers-5th-annual-global-healthcare" hreflang="en">Novavax, Inc. to Present at Lehman Brothers 5th Annual Global Healthcare Conference</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Feb 26, 2002 /PRNewswire-FirstCall via COMTEX/ -- - Conference Presentation May be Accessed via Live Conference Call - NOVAVAX, INC. (Nasdaq: NVAX) today announced that John A....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> <li> <div class="col"> <div class="views-field views-field-field-nir-news-date"><div class="field-content"> <div class="field field--name-field-nir-news-date field--type-datetimezone field--label-above"> <div class="field__item">Feb 20, 2002 </div> <div class="pdf-title-link"><a href= "javascript:window.print();" class="ndqicon-print-link" ><i class="icon ndqicon-print"></i></a> </div> </div> </div></div> <div class="views-field views-field-field-nir-news-title"><div class="field-content"> <div class="news-title"> <h4><a href="/news-releases/news-release-details/novavax-inc-announces-2001-fourth-quarter-and-year-end-financial" hreflang="en">Novavax, Inc. Announces 2001 Fourth Quarter and Year End Financial Results</a></h4> </div> </div></div> <div class="views-field views-field-field-nir-news-teaser"><div class="field-content summary-hidden"> <div class="teaserText"> <p>COLUMBIA, Md., Feb 20, 2002 /PRNewswire-FirstCall via COMTEX/ -- NOVAVAX, INC. (Nasdaq: NVAX) today announced financial results for the fourth quarter and year ended December 31, 2001....<a class="ccbnLnk" href="javascript;">More</a>>></p> </div> </div></div> </div> </li> </ul> </div> </div> <div class="view-footer"> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div><!-- /.boxton --> </div> </article> </div> </div> </div> </section> </div> </div> <div class="container"> <div class="toolkit"><table border="0" cellspacing="1" cellpadding="3" width="100%"><tbody><tr class="ccbnBgLnk"><td valign="top" align="center"><span class="ccbnLnk"><a class="ccbnLnk" href="#" onclick="javascript:window.print();">Print Page</a></span><span class="ccbnTxt"> | </span><span class="ccbnLnk"><a href="/email-alerts" name="" class="ccbnLnk">Join Our E-mail Alert List</a></span></td></tr></tbody></table></div> </div> </div> <footer id="page-footer"> <div class="container"> <div class="footer-logo"> <a href="https://novavax.com"> <img src="/sites/g/files/knoqqb54086/themes/site/nir_pid165/client/new-images/novavax-logo-knockout.png" alt=""> </a> </div> <div class="footer-navigation"> <nav id="footer-primary-nav" role="navigation" aria-label="sitemap main"> <ul class="nav-items"> <li class="nav-item"> <ul class="nav-items--stacked"> <li class="nav-item"> <a href="https://novavax.com/about-us" target="" rel="">About Us</a> </li> <li class="nav-item"> <a href="https://novavax.com/our-pipeline" target="" rel="">Our Pipeline</a> </li> <li class="nav-item"> <a href="https://novavax.com/science-and-technology-overview" target="" rel="">Science and Technology</a> </li> <li class="nav-item"> <a href="https://novavax.com/resources" target="" rel="">Resources</a> </li> <li class="nav-item"> <a href="https://novavax.com/careers" target="" rel="">Careers</a> </li> </ul> </li> <li class="nav-item"> <a href="/">For Investors</a> <ul class="sub-nav-items"> <li class="nav-item"> <a href="https://novavax.com/about-us#corporate-governance" target="" rel="">Corporate Governance</a> </li> <li class="nav-item"> <a href="https://novavax.com/2019_02_27_ResVax_Draft.pdf" target="_blank" rel="">Investor Presentation</a> </li> <li class="nav-item"> <a href="/stock-information/stock-quote-chart" target="" rel="" data-drupal-link-system-path="node/5911">Stock Information</a> </li> <li class="nav-item"> <a href="/events" target="" rel="" data-drupal-link-system-path="node/5826">Events</a> </li> <li class="nav-item"> <a href="/sec-filings" target="" rel="" data-drupal-link-system-path="node/13076">SEC Filings</a> </li> <li class="nav-item"> <a href="https://novavax.com/analyst-coverage" target="" rel="">Analyst Coverage</a> </li> <li class="nav-item"> <a href="https://novavax.com/investor-relations-contact" target="" rel="">Investor Relations Contact</a> </li> </ul> </li> <li class="nav-item"> <a href="https://novavax.com/novavax-in-the-news">News</a> <ul class="sub-nav-items"> <li class="nav-item menu-item--active-trail"> <a href="/press-releases" target="" rel="" data-drupal-link-system-path="node/5816" class="is-active">Press Releases</a> </li> <li class="nav-item"> <a href="https://novavax.com/novavax-in-the-news" target="" rel="">Novavax in the News</a> </li> <li class="nav-item"> <a href="/join-press-release-list" target="" rel="" data-drupal-link-system-path="node/13161">Join the Press Release List</a> </li> <li class="nav-item"> <a href="https://novavax.com/contact-us" target="" rel="">Contact Us</a> </li> </ul> </li> </ul> </nav> <div class="footer-navigation-divider"></div> <nav id="footer-utility-nav" aria-label="sitemap utility"> <ul class="nav-items"> <li class="nav-item"> <a>Contact Us</a> <ul class="sub-nav-items"> <li class="nav-item"> <p>21 Firstfield Road<br> Gaithersburg, MD 20878</p> <p>(240) 268-2000</p> </li><li> </li></ul> </li> <li class="nav-item"> <a>Social</a> <ul class="sub-nav-items"> <li class="nav-item nav-item-inline-links"> <a href="https://www.youtube.com/channel/UCrNorBVidJqLcfgKPkMdQVQ" target="_blank" rel="noopener noreferrer"> <img src="/sites/g/files/knoqqb54086/themes/site/nir_pid165/client/new-images/icon-youtube.svg" width="36" height="36"> </a> <a href="https://www.linkedin.com/company/novavax" target="_blank" rel="noopener noreferrer"> <img src="/sites/g/files/knoqqb54086/themes/site/nir_pid165/client/new-images/icon-linkedin.svg" width="36" height="36"> </a> <a href="https://twitter.com/novavax" target="_blank" rel="noopener noreferrer"> <img src="/sites/g/files/knoqqb54086/themes/site/nir_pid165/client/new-images/icon-twitter.svg" width="36" height="36"> </a> </li> </ul> </li> <li class="nav-item"> <ul class="sub-nav-items"> <li class="nav-item nav-item-inline-links"> <a>&nbsp;</a> <p><a href="https://novavax.com/privacy-policy">Privacy Policy</a> <span class="divider">|</span> <a href="https://novavax.com/terms-and-conditions">Terms and Conditions</a></p> <p><a href="https://novavax.com/download/files/policy/OFCCP_Pay_Transparency_Nondiscrimination_Provision.pdf" target="_blank" rel="noopener noreferrer">Pay Transparency Nondiscrimination Provision</a></p> <p><a href="https://novavax.com/download/files/policy/NVAX_PO_Language_2016-12-01.pdf" target="_blank" rel="noopener noreferrer">Purchase Order Terms and Conditions</a></p> </li><li> </li> </ul> </li> </ul> </nav> </div> </div> </footer> <div class="privacy-popup"> <div class="privacy-popup-inner"> <div class="privacy-popup-content"> <p>This site uses cookies and similar technologies to provide you with our services, enhance the performance and functionality of our services, and analyze the use of our products and services. By clicking ‘Accept’ you are indicating your consent for us to place these cookies. For more information, please read our <a href="https://novavax.com/privacy-policy" target="_blank" rel="noopener noreferrer">Privacy Policy</a> or manage your cookie settings.</p> </div> <div class="privacy-popup-accept"> <span style="text-decoration: underline;">Accept<span> <img class="mobile-item-toggle" src="/sites/g/files/knoqqb54086/themes/site/nir_pid165/client/new-images/expand-white.png" width="8" height="auto"/> </div> </div> </div> </div> <script type="text/javascript">var s_CCSWebHostingAccount = "trcgclientweb3389";</script> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"node\/5816","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"classy\/node,core\/drupal.collapse,core\/html5shiv,nir_base\/adobe_omniture,nir_base\/lib,nir_base\/nir_icons,nir_base\/nir_toolbar,nir_ckeditor_datatables\/datatables,nir_multimedia\/nir_multimedia,nir_pid165\/override,nir_website_notices\/nir_website_notices.notices,radix_layouts\/radix_layouts,system\/base,views\/views.module","theme":"nir_pid165","theme_token":null},"ajaxTrustedUrl":{"\/press-releases":true},"user":{"uid":0,"permissionsHash":"aa13756e8217b57d3d0c9dfc54951903eb5c5ed46acab2aabb8fca017da52910"}}</script> <script src="/sites/g/files/knoqqb54086/files/js/js_5_jO2tNMBeuOnu4AtnxL8OHFfsE23OZYfjgKxWCVnoQ.js"></script> <script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"761e715901","applicationID":"35893545,24276188","transactionName":"ZlVXYRcAW0ZRW0QKX18fdFYRCFpbH3xCFkBQXGlbCgVQaXNXXhdCXlxZUBc9e1pUXWYKVUZzWlsRE1pZXF1CTg5HWVBC","queueTime":0,"applicationTime":1980,"atts":"ShJUF18aSEg=","errorBeacon":"bam.nr-data.net","agent":""}</script></body> </html>